GLP-1 Market
LLY $1170.14 ▲ +0.5% NVO $39.40 ▼ -1.0% PFE $27.93 ▲ +0.7% VKTX $40.85 ▲ +35.7% KLRA $12.79 ▲ +6.7% GPCR $36.91 ▲ +0.3% RHHBY $55.56 ▲ +0.5%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Cyclophosphamide

Company
Huashan Hospital
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
81 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

81 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 23, 2026

Find a Clinical Trial Near Me

See recruiting studies for Cyclophosphamide and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT01174121

    Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

    Not yet reported National Cancer Institute (NCI) 332 participants Est. completion 2029-12-27 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer, Metastatic Breast Carcinoma, Metastatic Endocrine Tumors/ Neuroendocrine Tumors
    View official trial listing →
  • Recruiting NCT NCT01861106

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

    Not yet reported National Cancer Institute (NCI) 144 participants Est. completion 2028-12-31 1 site
    Other conditions: GATA2, Immunodeficiency, MDS
    View official trial listing →
  • Recruiting NCT NCT01949129

    Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

    Not yet reported, Not yet reported St. Anna Kinderkrebsforschung 1800 participants Est. completion 2030-06-01 119 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukaemia
    View official trial listing →
  • Recruiting NCT NCT03128996

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

    Not yet reported, Not yet reported Washington University School of Medicine 29 participants Est. completion 2033-04 4 sites Stand-alone
    Other conditions: Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders, Immunologic Disorders, Hemoglobinopathies, Non-malignant Disorders
    View official trial listing →
  • Recruiting NCT NCT03802773

    Cord Blood Transplantation With Myeloablative Conditioning and Post-transplant Cyclophosphamide (COmPACt Study)

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 10 participants Est. completion 2025-12-31 1 site
    Other conditions: Cord Blood Transplantation, Hematological Malignancies
    View official trial listing →
  • Recruiting NCT NCT03909412

    Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma

    Not yet reported Hackensack Meridian Health 18 participants Est. completion 2027-08 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Recruiting NCT NCT03938987

    Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)

    Not yet reported, Not yet reported University of Alberta 63 participants Est. completion 2027-12 6 sites Stand-alone
    Other conditions: Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL, Relapsed Pediatric ALL
    View official trial listing →
  • Recruiting NCT NCT04061512

    Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia

    Not yet reported, Not yet reported University College, London 148 participants Est. completion 2030-03 25 sites
    Other conditions: Waldenstrom Macroglobulinemia
    View official trial listing →
  • Recruiting NCT NCT04083495

    CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

    Not yet reported UNC Lineberger Comprehensive Cancer Center 20 participants Est. completion 2038-08 2 sites Stand-alone
    Other conditions: Peripheral T Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT04221035

    High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 800 participants Est. completion 2032-11 142 sites Stand-alone
    Other conditions: High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
    View official trial listing →
  • Recruiting NCT NCT04332822

    A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

    Not yet reported Nordic Lymphoma Group 300 participants Est. completion 2028-12-28 69 sites Stand-alone
    Other conditions: DLBCL, Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT04440267

    Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 50 participants Est. completion 2027-12-20 1 site Stand-alone
    Other conditions: Acute Leukemia of Ambiguous Lineage
    View official trial listing →
  • Recruiting NCT NCT04510051

    CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children

    Not yet reported City of Hope Medical Center 18 participants Est. completion 2027-02-24 3 sites Stand-alone
    Other conditions: Malignant Brain Neoplasm, Recurrent Malignant Brain Neoplasm, Refractory Malignant Brain Neoplasm
    View official trial listing →
  • Recruiting NCT NCT04570423

    A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

    Not yet reported Spectrum Pharmaceuticals, Inc 40 participants Est. completion 2027-10 5 sites Stand-alone
    Other conditions: Solid Tumors, Lymphoma
    View official trial listing →
  • Recruiting NCT NCT04745949

    PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy

    Not yet reported M.D. Anderson Cancer Center 31 participants Est. completion 2027-08-03 1 site Stand-alone
    Other conditions: Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT04803201

    Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

    Not yet reported Alliance for Clinical Trials in Oncology 170 participants Est. completion 2027-05-19 96 sites Stand-alone
    Other conditions: Angioimmunoblastic T-cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Follicular T-Cell Lymphoma, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Peripheral T-Cell Lymphoma, Not Otherwise Specified
    View official trial listing →
  • Recruiting NCT NCT04925856

    Immunomonitoring of Breast Cancer Patients During Systemic Treatment

    Not yet reported Centre Georges Francois Leclerc 150 participants Est. completion 2030-05-26 2 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05040555

    R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden

    Not yet reported oubai, MD/PhD 64 participants Est. completion 2028-09-01 1 site Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3B
    View official trial listing →
  • Recruiting NCT NCT05099471

    Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia

    Not yet reported Christian Buske 80 participants Est. completion 2033-03 14 sites
    Other conditions: Waldenstrom Macroglobulinemia, Treatment Naive
    View official trial listing →
  • Recruiting NCT NCT05126849

    Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression

    Not yet reported Assistance Publique - Hôpitaux de Paris 31 participants Est. completion 2027-01-06 35 sites Stand-alone
    Other conditions: Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Recruiting NCT NCT05159193

    Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 372 participants Est. completion 2028-01-31 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05269381

    Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

    Not yet reported, Not yet reported Mayo Clinic 138 participants Est. completion 2028-03-31 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVB Gastric Cancer AJCC v8, Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8, Locally Advanced Cervical Carcinoma, Locally Advanced Endometrial Carcinoma, Locally Advanced Gastric Adenocarcinoma, Locally Advanced Gastroesophageal Junction Adenocarcinoma, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced Hepatocellular Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Locally Advanced Malignant Solid Neoplasm, Locally Advanced Melanoma, Locally Advanced Merkel Cell Carcinoma, Locally Advanced Renal Cell Carcinoma, Locally Advanced Skin Squamous Cell Carcinoma, Locally Advanced Triple-Negative Breast Carcinoma, Locally Advanced Unresectable Breast Carcinoma, Locally Advanced Unresectable Cervical Carcinoma, Locally Advanced Unresectable Gastric Adenocarcinoma, Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma, Locally Advanced Unresectable Renal Cell Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Cervical Carcinoma, Metastatic Endometrial Carcinoma, Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hepatocellular Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Melanoma, Metastatic Merkel Cell Carcinoma, Metastatic Renal Cell Carcinoma, Metastatic Skin Squamous Cell Carcinoma, Metastatic Triple-Negative Breast Carcinoma, Metastatic Urothelial Carcinoma, Skin Squamous Cell Carcinoma, Stage III Cervical Cancer AJCC v8, Stage III Hepatocellular Carcinoma AJCC v8, Stage III Lung Cancer AJCC v8, Stage III Renal Cell Cancer AJCC v8, Stage IIIA Cervical Cancer AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIA Uterine Corpus Cancer AJCC v8, Stage IIIB Cervical Cancer AJCC v8, Stage IIIB Hepatocellular Carcinoma AJCC v8, Stage IIIB Lung Cancer AJCC v8, Stage IIIB Uterine Corpus Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8, Stage IIIC Uterine Corpus Cancer AJCC v8, Stage IIIC1 Uterine Corpus Cancer AJCC v8, Stage IIIC2 Uterine Corpus Cancer AJCC v8, Stage IV Cervical Cancer AJCC v8, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8, Stage IVA Cervical Cancer AJCC v8, Stage IVA Hepatocellular Carcinoma AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVA Uterine Corpus Cancer AJCC v8, Stage IVB Cervical Cancer AJCC v8, Stage IVB Hepatocellular Carcinoma AJCC v8, Stage IVB Lung Cancer AJCC v8, Stage IVB Uterine Corpus Cancer AJCC v8, Triple-Negative Breast Carcinoma, Unresectable Cervical Carcinoma, Unresectable Endometrial Carcinoma, Unresectable Gastric Adenocarcinoma, Unresectable Gastroesophageal Junction Adenocarcinoma, Unresectable Head and Neck Squamous Cell Carcinoma, Unresectable Hepatocellular Carcinoma, Unresectable Lung Non-Small Cell Carcinoma, Unresectable Malignant Solid Neoplasm, Unresectable Melanoma, Unresectable Merkel Cell Carcinoma, Unresectable Renal Cell Carcinoma, Unresectable Skin Squamous Cell Carcinoma, Unresectable Triple-Negative Breast Carcinoma, Unresectable Urothelial Carcinoma, Breast Adenocarcinoma, Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Invasive Breast Lobular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05462613

    Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Centre Hospitalier Universitaire de Besancon 446 participants Est. completion 2030-11 16 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT05518383

    B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

    Not yet reported Federal Research Institute of Pediatric Hematology, Oncology and Immunology 300 participants Est. completion 2027-05-16 1 site Stand-alone
    Other conditions: Non-hodgkin Lymphoma,B Cell, Burkitt Lymphoma, Primary Mediastinal Lymphoma, Primary CNS Lymphoma, Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05567198

    Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 100 participants Est. completion 2027-05-31 1 site
    Other conditions: Systemic Lupus Erythematosus (Sle), Primary Ovarian Insufficiency (Poi)
    View official trial listing →
  • Recruiting NCT NCT05656573

    CART-PSMA Cells for Advanced Prostate Cancer

    Not yet reported Nova Therapeutics LLC 20 participants Est. completion 2025-12-01 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT05660473

    Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 100 participants Est. completion 2027-12-30 1 site Stand-alone
    Other conditions: Precursor Cell Lymphoblastic Leukemia-Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05681650

    HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors

    Not yet reported, Not yet reported Chinese PLA General Hospital 30 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: HER2 Positive Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT05876065

    Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer

    Not yet reported Wenjin Yin 86 participants Est. completion 2028-02 1 site Stand-alone
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05963217

    Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL

    Not yet reported University Health Network, Toronto 19 participants Est. completion 2028-06-30 1 site Stand-alone
    Other conditions: Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05981001

    Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

    Not yet reported, Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 170 participants Est. completion 2035-04-30 1 site Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Recruiting NCT NCT06005870

    Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression

    Not yet reported Huazhong University of Science and Technology 41 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06023641

    Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

    Not yet reported St. Jude Children's Research Hospital 135 participants Est. completion 2037-10 3 sites Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Recruiting NCT NCT06042569

    Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial

    Not yet reported City of Hope Medical Center 174 participants Est. completion 2030-03-20 3 sites Stand-alone
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06043466

    A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

    Not yet reported Chongqing Precision Biotech Co., Ltd 30 participants Est. completion 2027-12-31 2 sites Stand-alone
    Other conditions: Colorectal Cancer, Esophagus Cancer, Gastric Cancer, Pancreas Cancer, Non-small Cell Lung Cancer, Breast Cancer, Bile Duct Cancer
    View official trial listing →
  • Recruiting NCT NCT06060782

    Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine

    Not yet reported Fifth Affiliated Hospital, Sun Yat-Sen University 28 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult
    View official trial listing →
  • Recruiting NCT NCT06083883

    Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1

    Not yet reported M.D. Anderson Cancer Center 44 participants Est. completion 2028-11-30 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Synovial Sarcoma
    View official trial listing →
  • Recruiting NCT NCT06092047

    UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.

    Not yet reported PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10 participants Est. completion 2028-04 1 site Stand-alone
    Other conditions: CD19-positive Relapsed or Refractory B-cell Malignancies
    View official trial listing →
  • Recruiting NCT NCT06107673

    Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）

    Not yet reported Hebei Medical University Fourth Hospital 144 participants Est. completion 2028-12-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06119685

    IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

    Not yet reported, Not yet reported Indapta Therapeutics, INC. 128 participants Est. completion 2029-12-31 12 sites Stand-alone
    Other conditions: NHL, Multiple Myeloma, Blood Cancer, Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Multiple Myeloma, Relapsed Multiple Myeloma
    View official trial listing →
  • Recruiting NCT NCT06142396

    Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure

    Not yet reported Augusta University 30 participants Est. completion 2027-11-01 1 site Stand-alone
    Other conditions: Multiple Myeloma, Renal Failure
    View official trial listing →
  • Recruiting NCT NCT06158399

    AZA Combined With RCHOP in P53-mutated DLBCL.

    Not yet reported The First Affiliated Hospital of Xiamen University 52 participants Est. completion 2026-05-31 1 site Stand-alone
    Other conditions: DLBCL - Diffuse Large B Cell Lymphoma, TP53
    View official trial listing →
  • Recruiting NCT NCT06186401

    Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

    Not yet reported Hideho Okada, MD, PhD 20 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: EGFR Gene Mutation, Glioblastoma, MGMT-Unmethylated Glioblastoma, Recurrent Glioblastoma
    View official trial listing →
  • Recruiting NCT NCT06215950

    A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer

    Not yet reported Chongqing Precision Biotech Co., Ltd 36 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Ovarian Cancer, Cervix Cancer, Metastatic Cancer, Advanced Cancer, Gynecologic Cancer
    View official trial listing →
  • Recruiting NCT NCT06249256

    An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells

    Not yet reported Shanghai Cell Therapy Group Co.,Ltd 12 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT06313957

    A Study of LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

    Not yet reported Peking University Cancer Hospital & Institute 42 participants Est. completion 2028-09 3 sites Stand-alone
    Other conditions: Relapsed B-cell Non-Hodgkin Lymphoma, Refractory B-cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06328777

    RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

    Not yet reported, Not yet reported Cabaletta Bio 37 participants Est. completion 2029-07 10 sites Stand-alone
    Other conditions: Systemic Sclerosis, Scleroderma, Interstitial Lung Diseases
    View official trial listing →
  • Recruiting NCT NCT06383572

    Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 44 participants Est. completion 2029-04-01 1 site Stand-alone
    Other conditions: Lymphodepleting Chemotherapy, Myeloid Malignancies
    View official trial listing →
  • Recruiting NCT NCT06486051

    A Study of Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma

    Not yet reported Malaghan Institute of Medical Research 60 participants Est. completion 2029-06-30 3 sites Stand-alone
    Other conditions: Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Transformed Non-Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06494371

    A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma

    Not yet reported Ruijin Hospital 32 participants Est. completion 2028-08 1 site Stand-alone
    Other conditions: Hodgkin's Lymphoma, Anaplastic Large Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06517641

    Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

    Not yet reported Medical College of Wisconsin 60 participants Est. completion 2029-02-01 25 sites
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Recruiting NCT NCT06611813

    Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)

    Not yet reported First Affiliated Hospital of Zhejiang University 30 participants Est. completion 2029-06 11 sites Stand-alone
    Other conditions: HR+/HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06615050

    A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

    Not yet reported Incyte Corporation 572 participants Est. completion 2031-01-17 30 sites
    Other conditions: Graft-versus-host Disease (GVHD)
    View official trial listing →
  • Recruiting NCT NCT06622694

    CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 15 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Severe Aplastic Anemia, Relapse, Refractory, CAR T-cell Therapy
    View official trial listing →
  • Recruiting NCT NCT06718738

    Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer

    Not yet reported Beijing Immunochina Medical Science & Technology Co., Ltd. 9 participants Est. completion 2026-08-15 1 site Stand-alone
    Other conditions: Colorectal Cancer (CRC)
    View official trial listing →
  • Recruiting NCT NCT06721962

    Treatment of Moderate to Severe Refractory Crohn's Disease

    Not yet reported, Not yet reported Tr1X, Inc. 39 participants Est. completion 2027-01-30 13 sites Stand-alone
    Other conditions: Crohns Disease
    View official trial listing →
  • Recruiting NCT NCT06768151

    A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer

    Not yet reported Chongqing Precision Biotech Co., Ltd 48 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Advanced Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT06783270

    T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma

    Not yet reported Inge Marie Svane 10 participants Est. completion 2028-01-01 1 site Stand-alone
    Other conditions: Melanoma Metastatic
    View official trial listing →
  • Recruiting NCT NCT06800391

    Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients

    Not yet reported Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 31 participants Est. completion 2029-11 1 site Stand-alone
    Other conditions: Pseudomyxoma Peritonei
    View official trial listing →
  • Recruiting NCT NCT06816771

    Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents

    Not yet reported Shandong Cancer Hospital and Institute 38 participants Est. completion 2026-12-31 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Recruiting NCT NCT06834282

    CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

    Not yet reported CERo Therapeutics Holdings, Inc. 18 participants Est. completion 2029-12-31 5 sites Stand-alone
    Other conditions: AML, Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT06891157

    Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 148 participants Est. completion 2027-08-20 1 site Stand-alone
    Other conditions: Chidamide, R-CHOP Chemotherapy, DLBCL - Diffuse Large B Cell Lymphoma, Double-expressor Lymphoma (DEL)
    View official trial listing →
  • Recruiting NCT NCT06897930

    A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

    Not yet reported, Not yet reported AstraZeneca 150 participants Est. completion 2029-05-01 20 sites Stand-alone
    Other conditions: Lupus Erythematosus, Systemic
    View official trial listing →
  • Recruiting NCT NCT06912152

    MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors

    Not yet reported Zhejiang University 12 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: B7-H3-positive Advanced Malignant Solid Tumors Advanced Primary Peritoneal Tumors or Secondary Abdominal Metastatic Malignant Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT06947460

    CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

    Not yet reported, Not yet reported Beijing GoBroad Hospital 45 participants Est. completion 2026-07-31 1 site Stand-alone
    Other conditions: Refractory Lupus Nephritis, Systemic Sclerosis, Primary Sjogren's Syndrome Combined With Pulmonary Hypertension, Other Autoimmune Diseases (AID)
    View official trial listing →
  • Recruiting NCT NCT06954805

    Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

    Not yet reported Jennifer Amengual 30 participants Est. completion 2028-04-14 2 sites Stand-alone
    Other conditions: Lymphoma, Lymphoma, B-Cell
    View official trial listing →
  • Recruiting NCT NCT06995521

    Vorinostat for Graft-versus-host Disease (GVHD) Prevention in Non-Malignant Adolescent and Young Adults (AYA) Population

    Not yet reported Sung Won Choi 55 participants Est. completion 2028-09 1 site Stand-alone
    Other conditions: GVHD
    View official trial listing →
  • Recruiting NCT NCT06996132

    Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 25 participants Est. completion 2027-12-30 1 site Stand-alone
    Other conditions: Relapsed or Refractory Aggressive B-cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT07009002

    BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

    Not yet reported, Not yet reported Chinese PLA General Hospital 30 participants Est. completion 2027-05-31 1 site Stand-alone
    Other conditions: B Cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT07011004

    A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

    Not yet reported Memorial Sloan Kettering Cancer Center 18 participants Est. completion 2028-05 7 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse
    View official trial listing →
  • Recruiting NCT NCT07066995

    Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer

    Not yet reported, Not yet reported Essen Biotech 60 participants Est. completion 2028-12-28 1 site Stand-alone
    Other conditions: Pancreatic Cancer, Pancreatic Carcinoma, Pancreatic Cancer Non-resectable, Pancreatic Cancer Stage IV
    View official trial listing →
  • Recruiting NCT NCT07074951

    Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

    Not yet reported St. Petersburg State Pavlov Medical University 240 participants Est. completion 2027-12-10 2 sites Stand-alone
    Other conditions: Primary IgA-nephropathy, High-risk, Caucasians
    View official trial listing →
  • Recruiting NCT NCT07148791

    Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease

    Not yet reported Chinese PLA General Hospital 9 participants Est. completion 2029-12-31 1 site Stand-alone
    Other conditions: IgG4 Related Disease, B-cell Mediated Autoimmune Disorders
    View official trial listing →
  • Recruiting NCT NCT07255664

    A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC

    Not yet reported, Not yet reported CuraCell TX AB 12 participants Est. completion 2029-04 1 site
    Other conditions: Metastatic Colorectal Cancer, Prostate Cancer Metastatic, Prostate Cancer Locally Advanced
    View official trial listing →
  • Recruiting NCT NCT07283315

    Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases

    Not yet reported The Children's Hospital of Zhejiang University School of Medicine 12 participants Est. completion 2029-12-30 1 site Stand-alone
    Other conditions: Paediatric B Cell-related Autoimmune Diseases, Autoimmune Diseases, CAR
    View official trial listing →
  • Recruiting NCT NCT07294677

    CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL

    Not yet reported, Not yet reported University of Chicago 104 participants Est. completion 2032-03 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Recruiting NCT NCT07306156

    GP350 CAR-T for Relapse/Refractory and Epstein-Barr Virus Infection Associated Lymphoid Neoplasms

    Not yet reported, Not yet reported Zhimin Zhai 24 participants Est. completion 2032-11-20 1 site Stand-alone
    Other conditions: EBV Associated Lymphoid Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07349160

    Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 36 participants Est. completion 2028-01-20 1 site Stand-alone
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT07454382

    A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma

    Not yet reported Memorial Sloan Kettering Cancer Center 26 participants Est. completion 2029-08-27 7 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Recruiting NCT NCT07627711

    Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

    Not yet reported, Not yet reported Beijing Biotech 42 participants Est. completion 2028-03-17 1 site Stand-alone
    Other conditions: Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced, Metastatic Disease
    View official trial listing →
  • Recruiting NCT NCT07654426

    The CARDIOPROTECT Trial

    Not yet reported Beth Israel Deaconess Medical Center 60 participants Est. completion 2035-12-31 1 site Stand-alone
    Other conditions: Diffuse Large B-cell Lymphoma (DLBCL), Cardiotoxicity, Lymphoma
    View official trial listing →
  • Completed NCT NCT00000703

    Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 45 participants Est. completion 1990-03 14 sites
    Other conditions: Lymphoma, Non-Hodgkin, HIV Infections
    View official trial listing →
  • Completed NCT NCT00001676

    Cyclophosphamide and Fludarabine to Treat Lupus Nephritis

    Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15 participants Est. completion 2002-11 1 site
    Other conditions: Glomerulonephritis, Lupus Nephritis, Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00001748

    HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 35 participants Est. completion 2000-05 1 site
    Other conditions: Graft vs Host Disease, Hematologic Neoplasms, Lymphoma, Myelodysplastic Syndromes, Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT00002477

    Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer

    Not yet reported Medical Research Council 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00002509

    High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer

    Not yet reported, Not yet reported Temple University Est. completion 2003-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002510

    Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

    Not yet reported, Not yet reported Temple University Est. completion 2001-06 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00002516

    Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma

    Not yet reported University Hospital Muenster 1 site
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00002521

    Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

    Not yet reported Temple University Est. completion 2000-02 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00002524

    Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

    Not yet reported M.D. Anderson Cancer Center 46 participants Est. completion 2005-10 2 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00002546

    Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus

    Not yet reported Gynecologic Oncology Group 216 participants 65 sites
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00002547

    Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

    Not yet reported Barbara Ann Karmanos Cancer Institute 280 participants Est. completion 2003-10 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00002549

    Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 1520 participants 75 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002558

    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 108 participants Est. completion 2009-04 1 site
    Other conditions: Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00002576

    Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma

    Not yet reported Cancer Research Campaign Clinical Trials Centre 200 participants Est. completion 2001-01 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00002616

    Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer

    Not yet reported University of Illinois at Chicago 36 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00002641

    Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 350 participants Est. completion 2012-06 45 sites
    Other conditions: Endometrial Cancer, Kidney Cancer, Ovarian Cancer, Pheochromocytoma, Sarcoma
    View official trial listing →
  • Completed NCT NCT00002704

    Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

    Not yet reported National Cancer Institute (NCI) 156 participants 70 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002773

    Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer

    Not yet reported St. Vincent Medical Center - Los Angeles Est. completion 2004-04 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00002865

    High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

    Not yet reported Wake Forest University Health Sciences 25 participants Est. completion 2001-08 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002953

    Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer

    Not yet reported Medical Research Council 704 participants Est. completion 2005-11 19 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003050

    Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

    Not yet reported University of Southern California 46 participants Est. completion 2000-03 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003093

    Combination Chemotherapy in Treating Children With Neuroblastoma

    Not yet reported Children's Oncology Group 573 participants Est. completion 2011-01 235 sites Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00003203

    Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

    Not yet reported Children's Oncology Group 168 participants Est. completion 2012-03 38 sites Stand-alone
    Other conditions: Brain Tumors, Central Nervous System Tumors, Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00003340

    Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Est. completion 2000-02 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00003388

    Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

    Not yet reported Eastern Cooperative Oncology Group 38 participants 5 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00003573

    Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma

    Not yet reported Children's Oncology Group 53 participants Est. completion 2008-03 106 sites Stand-alone
    Other conditions: Brain Tumors, Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00003597

    Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

    Not yet reported Children's Oncology Group 16 participants Est. completion 2005-09 24 sites
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT00003784

    S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

    Not yet reported SWOG Cancer Research Network 102 participants 87 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00003893

    Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer

    Not yet reported University Hospital Birmingham 2250 participants Est. completion 2006-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003943

    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.

    Not yet reported Fox Chase Cancer Center 3 participants Est. completion 2003-02 2 sites
    Other conditions: Carcinoma of Unknown Primary, Lung Cancer
    View official trial listing →
  • Completed NCT NCT00004010

    Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease

    Not yet reported Children's Oncology Group 99 participants Est. completion 2008-06 40 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00004904

    Stem Cell Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported Northwestern University Est. completion 2000-07 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous/Nonmalignant Condition, Small Intestine Cancer
    View official trial listing →
  • Completed NCT NCT00004916

    Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

    Not yet reported, Not yet reported Northwestern University Est. completion 2002-10 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT00005090

    S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease

    Not yet reported SWOG Cancer Research Network 11 participants Est. completion 2005-05 47 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00005596

    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia

    Not yet reported Children's Oncology Group 1076 participants Est. completion 2007-07 123 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Terminated NCT NCT00005834

    S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma

    Not yet reported SWOG Cancer Research Network 19 participants Est. completion 2007-11 93 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT00006054

    Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies

    Not yet reported Fairview University Medical Center Est. completion 2002-12 1 site
    Other conditions: Immunologic Deficiency Syndromes, Chediak-Higashi Syndrome, Common Variable Immunodeficiency, Graft Versus Host Disease, X-Linked Lymphoproliferative Syndrome, Familial Erythrophagocytic Lymphohistiocytosis, Hemophagocytic Lymphohistiocytosis, X-linked Agammaglobulinemia, Wiskott-Aldrich Syndrome, Chronic Granulomatous Disease, X-linked Hyper IgM Syndrome, Severe Combined Immunodeficiency, Leukocyte Adhesion Deficiency Syndrome, Virus-Associated Hemophagocytic Syndrome
    View official trial listing →
  • Completed NCT NCT00006256

    Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer

    Not yet reported Case Comprehensive Cancer Center 44 participants Est. completion 2023-11-20 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00009997

    Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

    Not yet reported NYU Langone Health 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00010400

    Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome

    Not yet reported Johns Hopkins University 35 participants 2 sites
    Other conditions: Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome
    View official trial listing →
  • Completed NCT NCT00012051

    Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

    Not yet reported Commissie Voor Klinisch Toegepast Onderzoek 340 participants Est. completion 2007-10 17 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00022737

    Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia

    Not yet reported National Cancer Institute (NCI) 220 participants 1 site Stand-alone
    Other conditions: Childhood Acute Lymphoblastic Leukemia in Remission, Recurrent Childhood Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00023998

    Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma

    Not yet reported National Cancer Institute (NCI) 80 participants Est. completion 2007-05 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Status unknown NCT NCT00025324

    Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors

    Not yet reported Children's Hospital Los Angeles 4 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Status unknown NCT NCT00025402

    Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia

    Not yet reported III. Medizinische Klinik Mannheim 1000 participants 188 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00025428

    Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma

    Not yet reported Societe Internationale d'Oncologie Pediatrique 100 participants Est. completion 2013-11 12 sites
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00040937

    S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

    Not yet reported SWOG Cancer Research Network 147 participants Est. completion 2015-10 141 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00048737

    Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 70 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Lymphoma, Leukemia
    View official trial listing →
  • Completed NCT NCT00049517

    Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia

    Not yet reported Eastern Cooperative Oncology Group 657 participants Est. completion 2019-12 99 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00050167

    Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer

    Not yet reported M.D. Anderson Cancer Center 603 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00054587

    Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer

    Not yet reported UNICANCER 3010 participants Est. completion 2009-12 29 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00061984

    Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 455 participants Est. completion 2012-07 41 sites
    Other conditions: Sarcoma
    View official trial listing →
  • Terminated NCT NCT00066417

    Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 51 participants Est. completion 2007-01 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Status unknown NCT NCT00070278

    Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

    Not yet reported Cambridge University Hospitals NHS Foundation Trust 800 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00072566

    Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

    Not yet reported National Cancer Institute (NCI) 70 participants Est. completion 2008-11 1 site Stand-alone
    Other conditions: Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma, Stage IV Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00080925

    T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies

    Not yet reported National Institutes of Health Clinical Center (CC) 20 participants Est. completion 2010-12 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00088530

    BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)

    Not yet reported CTI BioPharma 140 participants Est. completion 2010-07 99 sites Stand-alone
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Active, not recruiting NCT NCT00092222

    Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

    Not yet reported National Cancer Institute (NCI) 75 participants Est. completion 2026-10-01 1 site
    Other conditions: Lymphoproliferative Disorder, HHV-8, Malignancy, HIV
    View official trial listing →
  • Terminated NCT NCT00125606

    Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide

    Not yet reported University Hospital Muenster 30 participants Est. completion 2011-07 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00129389

    FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients

    Not yet reported Spanish Breast Cancer Research Group 1925 participants Est. completion 2013-10-01 68 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00129922

    Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer

    Not yet reported Spanish Breast Cancer Research Group 1289 participants Est. completion 2007-12 64 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00131027

    High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL)

    Not yet reported Japan Adult Leukemia Study Group 240 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Lymphoblastic Leukemia, Acute
    View official trial listing →
  • Completed NCT NCT00146588

    Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer

    Not yet reported Craig A. Bunnell, MD, MPH 55 participants Est. completion 2004-12 2 sites
    Other conditions: Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    View official trial listing →
  • Completed NCT NCT00152139

    Stem Cell Transplantation for Patients With Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 33 participants Est. completion 2009-01 1 site
    Other conditions: Acute Lymphoblastic Leukemias, Acute Myelocytic Leukemia, Chronic Myeloid Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Hemoglobinuria, Paroxysmal, Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT00163761

    Efficacy Study of Outpatient Therapy for Lymphoma

    Not yet reported Bayside Health 90 participants Est. completion 2008-02 10 sites
    Other conditions: Non-Hodgkin's Lymphoma, Hodgkin's Disease
    View official trial listing →
  • Completed NCT NCT00173862

    Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC

    Not yet reported National Taiwan University Hospital 18 participants Est. completion 2006-06 1 site
    Other conditions: Transitional Cell Carcinoma
    View official trial listing →
  • Terminated NCT NCT00176930

    Stem Cell Transplant for Hematological Malignancy

    Not yet reported Masonic Cancer Center, University of Minnesota 330 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute, MDS, Leukemia, Lymphocytic, Chronic, JMML, Hodgkin's Disease, Non-hodgkin's Lymphoma, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00204646

    Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)

    Not yet reported University Hospital Tuebingen Est. completion 2006-12 1 site
    Other conditions: Sarcoma, Soft Tissue
    View official trial listing →
  • Completed NCT NCT00228358

    Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine

    Not yet reported University of Washington 8 participants 1 site Stand-alone
    Other conditions: HER2-positive Breast Cancer, Recurrent Breast Cancer, Recurrent Non-small Cell Lung Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Stage IV Breast Cancer, Stage IV Non-small Cell Lung Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Ovarian Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00233987

    S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma

    Not yet reported SWOG Cancer Research Network 98 participants Est. completion 2017-12 53 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00248547

    Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

    Not yet reported OHSU Knight Cancer Institute 40 participants Est. completion 2009-01 1 site
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT00274950

    Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors

    Not yet reported Children's Cancer and Leukaemia Group 105 participants 20 sites
    Other conditions: Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00281983

    Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia

    Not yet reported, Not yet reported German CLL Study Group 100 participants Est. completion 2010-07 13 sites Stand-alone
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00285389

    Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years

    Not yet reported French Innovative Leukemia Organisation 39 participants Est. completion 2008-12 3 sites Stand-alone
    Other conditions: Mantle Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00299182

    Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 50 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00303667

    Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 50 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia
    View official trial listing →
  • Terminated NCT NCT00307645

    IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis

    Not yet reported Assistance Publique - Hôpitaux de Paris 160 participants Est. completion 2009-08 2 sites
    Other conditions: ANCA Associated Systemic Vasculitis Including Wegener's, Granulomatosis and Microscopic Polyangiitis and, Renal Limited Vasculitis
    View official trial listing →
  • Completed NCT NCT00309569

    Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients

    Not yet reported Austrian Breast & Colorectal Cancer Study Group 429 participants Est. completion 2000-09 Stand-alone
    Other conditions: Early Stage Breast Cancer
    View official trial listing →
  • Completed NCT NCT00309842

    Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

    Not yet reported Masonic Cancer Center, University of Minnesota 213 participants Est. completion 2019-11-22 2 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelofibrosis, MDS, Refractory Anemia, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Non-Hodgkin's Lymphoma, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00335556

    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

    Not yet reported Children's Oncology Group 291 participants 187 sites Stand-alone
    Other conditions: Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Clear Cell Sarcoma of the Kidney, Papillary Renal Cell Carcinoma, Rhabdoid Tumor of the Kidney, Stage I Renal Cell Cancer, Stage I Renal Wilms Tumor, Stage II Renal Cell Cancer, Stage II Renal Wilms Tumor, Stage III Renal Cell Cancer, Stage III Renal Wilms Tumor, Stage IV Renal Cell Cancer, Stage IV Renal Wilms Tumor
    View official trial listing →
  • Status unknown NCT NCT00339118

    EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children

    Not yet reported Sheba Medical Center
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00346164

    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

    Not yet reported Children's Oncology Group 588 participants Est. completion 2022-03-31 187 sites
    Obstructive sleep apnea Other conditions: Adult Alveolar Soft-part Sarcoma, Adult Epithelioid Sarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Epithelioid Sarcoma, Childhood Malignant Mesenchymoma, Childhood Synovial Sarcoma, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    View official trial listing →
  • Completed NCT NCT00352027

    Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma

    Not yet reported St. Jude Children's Research Hospital 81 participants Est. completion 2022-11-15 6 sites Stand-alone
    Other conditions: Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00352378

    Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer

    Not yet reported National Cancer Center, Korea 209 participants Est. completion 2006-01 Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00356928

    Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 14 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Terminated NCT NCT00365274

    SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 6 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Anaplastic Large Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00379015

    Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer

    Not yet reported Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 38 participants Est. completion 2016-03 5 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00379574

    Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL

    Not yet reported, Not yet reported Asan Medical Center 49 participants Est. completion 2011-01 2 sites Stand-alone
    Other conditions: Lymphoma, Large-Cell, Diffuse, Lymphoma, B-Cell
    View official trial listing →
  • Completed NCT NCT00382109

    Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

    Not yet reported Children's Oncology Group 146 participants Est. completion 2017-06-30 50 sites Stand-alone
    Other conditions: B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00388349

    Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease

    Not yet reported Stanford University 146 participants Est. completion 2010-09 1 site Stand-alone
    Other conditions: Hodgkin Disease, Hodgkin's Lymphoma, Lymphoma
    View official trial listing →
  • Completed NCT NCT00394251

    Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

    Not yet reported Celgene 197 participants Est. completion 2008-02-01 27 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00397800

    Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma

    Not yet reported, Not yet reported Technical University of Munich 12 participants Est. completion 2013-05 12 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00401817

    Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell Lymphoma

    Not yet reported Weill Medical College of Cornell University 11 participants Est. completion 2013-11 2 sites Stand-alone
    Other conditions: Untreated Mantle Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00407888

    Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

    Not yet reported University of Washington 60 participants Est. completion 2012-07 1 site Stand-alone
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT00410163

    Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients

    Not yet reported GlaxoSmithKline 61 participants Est. completion 2013-05 2 sites
    Other conditions: Leukaemia, Lymphocytic, Chronic
    View official trial listing →
  • Completed NCT NCT00430105

    Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides

    Not yet reported, Not yet reported Cambridge University Hospitals NHS Foundation Trust 160 participants Est. completion 2004-04
    Other conditions: ANCA Associated Systemic Vasculitis, Wegener's Granulomatosis, Microscopic Polyangiitis
    View official trial listing →
  • Completed NCT NCT00430118

    Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia

    Not yet reported University Hospital Schleswig-Holstein 4559 participants Est. completion 2012-01 76 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00433537

    Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 77 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Stage I Mantle Cell Lymphoma, Stage III Mantle Cell Lymphoma, Stage IV Mantle Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT00439296

    ABT-751 With Chemotherapy for Relapsed Pediatric ALL

    Not yet reported, Not yet reported Therapeutic Advances in Childhood Leukemia Consortium 9 participants Est. completion 2009-09-23 5 sites Stand-alone
    Other conditions: Recurrent Pediatric ALL, Relapsed Pediatric ALL, Acute Lymphoblastic Leukemia, Refractory Pediatric ALL
    View official trial listing →
  • Completed NCT NCT00445744

    Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

    Not yet reported Fred Hutchinson Cancer Center 52 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Childhood Acute Myeloid Leukemia in Remission, Childhood Myelodysplastic Syndromes, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Myelodysplastic Syndrome With Isolated Del(5q), Polycythemia Vera, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Secondary Myelofibrosis, Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    View official trial listing →
  • Completed NCT NCT00450814

    Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma

    Not yet reported, Not yet reported Mayo Clinic 48 participants Est. completion 2019-11-20 1 site Stand-alone
    Other conditions: Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
    View official trial listing →
  • Terminated NCT NCT00473551

    Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies

    Not yet reported M.D. Anderson Cancer Center 4 participants Est. completion 2009-11 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Myeloma
    View official trial listing →
  • Terminated NCT NCT00486759

    A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

    Not yet reported Hoffmann-La Roche 787 participants Est. completion 2011-11-30 266 sites Stand-alone
    Other conditions: B-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00499083

    Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

    Not yet reported University of Nebraska 17 participants Est. completion 2010-01-28 2 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00504751

    Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL

    Not yet reported Weill Medical College of Cornell University 15 participants Est. completion 2012-02-17 1 site
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00526292

    Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant

    Not yet reported Memorial Sloan Kettering Cancer Center 12 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Terminated NCT NCT00544778

    Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma

    Not yet reported City of Hope Medical Center 7 participants
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00553202

    Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia

    Not yet reported Children's Oncology Group 158 participants Est. completion 2020-03-31 52 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00559104

    Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

    Not yet reported City of Hope Medical Center 60 participants Est. completion 2011-07 2 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00574587

    Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

    Not yet reported, Not yet reported Albert Einstein College of Medicine 55 participants Est. completion 2014-05 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00576979

    Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

    Not yet reported, Not yet reported City of Hope Medical Center 51 participants Est. completion 2026-01-07 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Terminated NCT NCT00589316

    Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome

    Not yet reported Fred Hutchinson Cancer Center 26 participants Est. completion 2021-10-01 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, CD45-Positive Neoplastic Cells Present, Chronic Myelomonocytic Leukemia, Previously Treated Myelodysplastic Syndrome, Refractory Anemia With Excess Blasts, Refractory Anemia With Ring Sideroblasts, Refractory Cytopenia With Multilineage Dysplasia, Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts
    View official trial listing →
  • Completed NCT NCT00591851

    Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility

    Not yet reported Memorial Sloan Kettering Cancer Center 70 participants Est. completion 2008-06 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00595127

    Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine

    Not yet reported Memorial Sloan Kettering Cancer Center 21 participants Est. completion 2013-05 1 site Stand-alone
    Other conditions: Fanconi Anemia
    View official trial listing →
  • Completed NCT NCT00596154

    Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

    Not yet reported Memorial Sloan Kettering Cancer Center 33 participants Est. completion 2023-02-02 3 sites Stand-alone
    Other conditions: CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00601796

    Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 24 participants Est. completion 2012-06 1 site Stand-alone
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00602693

    T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer

    Not yet reported Masonic Cancer Center, University of Minnesota 41 participants Est. completion 2015-04-16 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00604136

    Treatment of Metastatic Melanoma With Tumor Infiltrating Lymphocytes and IL-2 Following Lympho-depleting Chemotherapy

    Not yet reported Hadassah Medical Organization 20 participants Est. completion 2020-07 1 site
    Other conditions: Metastatic Melanoma
    View official trial listing →
  • Completed NCT NCT00610883

    LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma

    Not yet reported Memorial Sloan Kettering Cancer Center 17 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Terminated NCT NCT00612222

    Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma

    Not yet reported National Cancer Institute (NCI) 4 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Metastatic Melanoma, Skin Cancer
    View official trial listing →
  • Terminated NCT NCT00626197

    A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)

    Not yet reported Genentech, Inc. 381 participants Est. completion 2013-10-28 Stand-alone
    Other conditions: Lupus Nephritis, Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00630032

    Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer

    Not yet reported UNICANCER 762 participants Est. completion 2020-09-03 86 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00641095

    Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma

    Not yet reported, Not yet reported University College, London 370 participants Est. completion 2015-05-22 67 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00645606

    Rituximab Maintenance Versus Observation After First-line Immunochemotherapy by FCR in Older Patients With Chronic Lymphocytic Leukemia

    Not yet reported University Hospital, Tours 542 participants Est. completion 2017-07 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00653068

    Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System

    Not yet reported Children's Oncology Group 70 participants Est. completion 2024-03-31 94 sites Stand-alone
    Other conditions: Childhood Atypical Teratoid/Rhabdoid Tumor
    View official trial listing →
  • Completed NCT NCT00667342

    A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma

    Not yet reported St. Jude Children's Research Hospital 43 participants Est. completion 2017-08 5 sites
    Obstructive sleep apnea Other conditions: Malignant Fibrous Histiocytoma (MFH) of Bone
    View official trial listing →
  • Completed NCT NCT00671658

    Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia

    Not yet reported M.D. Anderson Cancer Center 220 participants Est. completion 2013-07 1 site Stand-alone
    Other conditions: Leukemia, Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00697671

    Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 48 participants Est. completion 2013-05 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00727441

    Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 87 participants Est. completion 2019-02 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00742924

    Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

    Not yet reported Children's Oncology Group 24 participants 88 sites
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00773695

    A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer

    Not yet reported Hoffmann-La Roche 150 participants Est. completion 2022-11-09 3 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00774202

    Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP

    Not yet reported, Not yet reported Weill Medical College of Cornell University 17 participants Est. completion 2008-02 1 site
    Other conditions: Immune Thrombocytopenic Purpura
    View official trial listing →
  • Status unknown NCT NCT00774826

    Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma

    Not yet reported Fondazione Italiana Linfomi - ETS 534 participants Est. completion 2014-03 82 sites
    Other conditions: Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT00775931

    Allogeneic Transplantation For Severe Osteopetrosis

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 7 participants Est. completion 2013-06 1 site
    Other conditions: Severe Osteopetrosis
    View official trial listing →
  • Completed NCT NCT00789776

    Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 41 participants Est. completion 2017-05 3 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Previously Treated Myelodysplastic Syndrome, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Indolent Adult Non-Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hodgkin Lymphoma, Refractory Plasma Cell Myeloma, Refractory Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00796562

    Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 107 participants Est. completion 2016-11 2 sites Stand-alone
    Other conditions: MDS, Leukemias, Lymphomas
    View official trial listing →
  • Completed NCT NCT00864318

    Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis

    Not yet reported Institut Claudius Regaud 101 participants Est. completion 2020-10-05 12 sites
    Other conditions: Germ Cell Tumors
    View official trial listing →
  • Completed NCT NCT00866905

    Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer

    Not yet reported SCRI Development Innovations, LLC 168 participants Est. completion 2014-10 20 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT00869232

    UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

    Not yet reported University of Arkansas 90 participants Est. completion 2028-10 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00877110

    Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

    Not yet reported Memorial Sloan Kettering Cancer Center 71 participants Est. completion 2019-01-07 1 site Stand-alone
    Other conditions: Neuroblastoma, Bone Marrow, Sympathetic Nervous System
    View official trial listing →
  • Terminated NCT NCT00880542

    Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery

    Not yet reported Jonsson Comprehensive Cancer Center 7 participants 1 site
    Other conditions: Sarcoma
    View official trial listing →
  • Status unknown NCT NCT00882323

    Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)

    Not yet reported The Korean Society of Pediatric Hematology Oncology 33 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00924170

    Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

    Not yet reported, Not yet reported National Cancer Institute (NCI) 18 participants Est. completion 2021-05-05 1 site Stand-alone
    Other conditions: Adult T-Cell Leukemia (ATL)
    View official trial listing →
  • Completed NCT NCT00940524

    Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

    Not yet reported Memorial Sloan Kettering Cancer Center 7 participants Est. completion 2014-04 1 site
    Other conditions: Leukemia, Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00958256

    Study of Bortezomib in Combination With Cyclophosphamide and Rituximab

    Not yet reported M.D. Anderson Cancer Center 22 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Mantle Cell Lymphoma, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00958854

    Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma

    Not yet reported Cancer Research UK 37 participants 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00959231

    Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease

    Not yet reported Cancer Research UK 60 participants 6 sites
    Other conditions: Hematopoietic/Lymphoid Cancer
    View official trial listing →
  • Completed NCT NCT00967369

    Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment.

    Not yet reported M.D. Anderson Cancer Center 20 participants Est. completion 2018-05-02 1 site
    Other conditions: Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma
    View official trial listing →
  • Terminated NCT NCT01005914

    Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

    Not yet reported OHSU Knight Cancer Institute 11 participants Est. completion 2014-05 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT01032681

    EMD 521873 in Advanced Solid Tumors, MTD Finding

    Not yet reported Merck KGaA, Darmstadt, Germany 66 participants Est. completion 2012-01 5 sites
    Other conditions: Non-Hodgkin Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT01044069

    Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19

    Not yet reported Memorial Sloan Kettering Cancer Center 93 participants Est. completion 2027-01 1 site
    Other conditions: Leukemia, Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT01046487

    Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate

    Not yet reported Centre Oscar Lambret 26 participants Est. completion 2012-02 3 sites
    Other conditions: Cancer
    View official trial listing →
  • Terminated NCT NCT01067989

    Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

    Not yet reported HaEmek Medical Center, Israel 22 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Chemotherapy, Breast Cancer, Metastatic
    View official trial listing →
  • Completed NCT NCT01074060

    Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma

    Not yet reported City of Hope Medical Center 18 participants Est. completion 2013-02 1 site Stand-alone
    Other conditions: Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01082939

    Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

    Not yet reported M.D. Anderson Cancer Center 80 participants Est. completion 2011-01 1 site Stand-alone
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Terminated NCT NCT01093183

    Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer

    Not yet reported, Not yet reported University of Nebraska 25 participants Est. completion 2015-05-19 1 site Stand-alone
    Other conditions: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01106898

    Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery

    Not yet reported University of Nebraska 112 participants Est. completion 2015-09-28 2 sites Stand-alone
    Other conditions: Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01106950

    Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML)

    Not yet reported Masonic Cancer Center, University of Minnesota 15 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Leukemia, Myelogenous, Acute
    View official trial listing →
  • Completed NCT NCT01121029

    Hematopoietic Stem Cell Transplantation in Type 1 Diabetes Mellitus

    Not yet reported, Not yet reported Dra. Olga Graciela Cantu Rodriguez 15 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT01143545

    Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

    Not yet reported National Cancer Institute (NCI) 10 participants Est. completion 2020-02-26 1 site Stand-alone
    Other conditions: Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma, Sarcoma, Thymic Carcinoma
    View official trial listing →
  • Completed NCT NCT01175356

    Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

    Not yet reported Children's Oncology Group 99 participants Est. completion 2025-12-31 25 sites Stand-alone
    Other conditions: Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
    View official trial listing →
  • Completed NCT NCT01177371

    High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

    Not yet reported Case Comprehensive Cancer Center 13 participants Est. completion 2010-02 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With T(15;17)(q22;q12), Adult Acute Myeloid Leukemia With T(16;16)(p13;q22), Adult Acute Myeloid Leukemia With T(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Acute Promyelocytic Leukemia (M3), Adult Erythroleukemia (M6a), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult Pure Erythroid Leukemia (M6b), Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Burkitt Lymphoma, Childhood Acute Erythroleukemia (M6), Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myeloid Leukemia in Remission, Childhood Acute Myelomonocytic Leukemia (M4), Childhood Acute Promyelocytic Leukemia (M3), Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, De Novo Myelodysplastic Syndromes, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Peripheral T-Cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01181258

    Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies

    Not yet reported Masonic Cancer Center, University of Minnesota 16 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01182415

    High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma

    Not yet reported Massachusetts General Hospital 30 participants Est. completion 2016-12 2 sites
    Other conditions: Non-Hodgkin's Lymphoma, CNS Lymphoma
    View official trial listing →
  • Completed NCT NCT01198665

    RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas

    Not yet reported, Not yet reported Samsung Medical Center 46 participants Est. completion 2014-12 5 sites
    Other conditions: Peripheral T Cell Lymphoma Unspecified, Anaplastic Large Cell Lymphoma, ALK-negative, Angioimmunoblastic T Cell Lymphoma, Cutaneous T Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01203722

    Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 87 participants Est. completion 2024-05-28 1 site
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Status unknown NCT NCT01222052

    6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients

    Not yet reported Martin-Luther-Universität Halle-Wittenberg 4150 participants Est. completion 2019-02 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01258634

    A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response

    Not yet reported University of Chicago 2 participants Est. completion 2011-11 1 site
    Obstructive sleep apnea Other conditions: Lung Metastases
    View official trial listing →
  • Completed NCT NCT01290120

    Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma

    Not yet reported Northern Italy Leukemia Group 182 participants Est. completion 2014-06 12 sites
    Other conditions: Burkitt Lymphoma, B-ALL
    View official trial listing →
  • Completed NCT NCT01315132

    A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 47 participants Est. completion 2019-08-29 1 site Stand-alone
    Other conditions: Hematological Malignancies, Leukemia, Lymphoma, Multiple Myeloma, Hodgkin's Disease
    View official trial listing →
  • Completed NCT NCT01319981

    Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia

    Not yet reported M.D. Anderson Cancer Center 31 participants Est. completion 2020-11-11 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT01328496

    Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative Regimen

    Not yet reported St. Jude Children's Research Hospital 14 participants Est. completion 2016-10-31 1 site
    Other conditions: Hematologic Malignancies, Disorder Related to Transplantation, Hematopoietic Malignancy
    View official trial listing →
  • Terminated NCT NCT01329640

    Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01)

    Not yet reported Instituto do Cancer do Estado de São Paulo 9 participants Est. completion 2012-09 1 site Stand-alone
    Other conditions: Locally Advanced HER2-positive Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01339910

    Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)

    Not yet reported Medical College of Wisconsin 272 participants Est. completion 2017-10-16 32 sites
    Other conditions: Leukemia, Myelocytic, Acute
    View official trial listing →
  • Terminated NCT NCT01341496

    Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal

    Not yet reported National Cancer Institute (NCI) 41 participants Est. completion 2016-07-21 1 site Stand-alone
    Other conditions: Sarcoma, Melanoma, Epithelial Malignancies, Pleural Malignancy
    View official trial listing →
  • Completed NCT NCT01343043

    A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma

    Not yet reported GlaxoSmithKline 50 participants Est. completion 2019-06-18 8 sites Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT01350245

    Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 28 participants Est. completion 2014-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Biphenotypic Leukemia, Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Plasma Cell Neoplasms, Lymphoma, Hodgkin's Disease, Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT01416038

    Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer

    Not yet reported ImmunoVaccine Technologies, Inc. (IMV Inc.) 19 participants Est. completion 2013-05 7 sites Stand-alone
    Other conditions: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
    View official trial listing →
  • Completed NCT NCT01422603

    Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML)

    Not yet reported, Not yet reported University Hospital Southampton NHS Foundation Trust 9 participants Est. completion 2015-03-31 1 site Stand-alone
    Other conditions: Acute Myeloid Leukaemia, Myelodysplasia
    View official trial listing →
  • Completed NCT NCT01432600

    Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide

    Not yet reported, Not yet reported H. Lee Moffitt Cancer Center and Research Institute 80 participants Est. completion 2016-08 3 sites Stand-alone
    Other conditions: Myeloma
    View official trial listing →
  • Completed NCT NCT01433562

    Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients

    Not yet reported, Not yet reported Dexa Medica Group 40 participants Est. completion 2012-11 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01446809

    Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma

    Not yet reported University of Washington 23 participants Est. completion 2019-01 1 site
    Other conditions: Stage IIA Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    View official trial listing →
  • Completed NCT NCT01481272

    Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients

    Not yet reported Polish Lymphoma Research Group 77 participants Est. completion 2018-12 8 sites
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01516580

    Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 482 participants Est. completion 2022-11-16 10 sites Stand-alone
    Other conditions: B-cell Non Hodgkin Lymphoma, Mature B-cell Leukemia Burkitt-type
    View official trial listing →
  • Completed NCT NCT01537029

    Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide

    Not yet reported Texas Tech University Health Sciences Center 15 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Breast Cancer, Obesity
    View official trial listing →
  • Status unknown NCT NCT01539902

    Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis

    Not yet reported CytoMed & Beike 25 participants Est. completion 2013-05 1 site
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT01547741

    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

    Not yet reported NSABP Foundation Inc 4242 participants Est. completion 2025-10-17 915 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01597219

    Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers

    Not yet reported University College, London 77 participants Est. completion 2024-01 12 sites Stand-alone
    Other conditions: Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia, Acute Lymphoblastic Leukaemia, Myelodysplastic Syndrome, Chronic Myeloid Leukaemia, Chronic Lymphocytic Leukaemia, Acquired Bone Marrow Failure Syndromes, Other Haematological Malignancies; Unrelated HSCT Indicated
    View official trial listing →
  • Completed NCT NCT01606878

    Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

    Not yet reported Children's Oncology Group 46 participants Est. completion 2018-12-31 23 sites Stand-alone
    Other conditions: Childhood Solid Neoplasm, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Neuroblastoma
    View official trial listing →
  • Completed NCT NCT01610869

    Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer

    Not yet reported University College, London 117 participants Est. completion 2018-01-11 16 sites Stand-alone
    Other conditions: Ovarian Cancer, Fallopian Tube Cancer
    View official trial listing →
  • Status unknown NCT NCT01622361

    Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer

    Not yet reported Asan Medical Center 290 participants Est. completion 2016-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01640301

    Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 47 participants Est. completion 2020-03-20 1 site Stand-alone
    Other conditions: Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia, Donor, Hematopoietic Cell Transplant Recipient, HLA-A*0201 Positive Cells Present, Recurrent Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01696461

    A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

    Not yet reported Center for International Blood and Marrow Transplant Research 127 participants Est. completion 2016-08 12 sites
    Other conditions: Related Donors Donating Peripheral Blood Stem Cells (PBSC) to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia, Non-Hodgkin's Lymphoma, Hodgkin's Disease, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01705691

    Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer

    Not yet reported NSABP Foundation Inc 50 participants Est. completion 2015-10 20 sites Stand-alone
    Other conditions: Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT01706666

    Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant

    Not yet reported Mayo Clinic 3 participants Est. completion 2016-05-17 4 sites Stand-alone
    Other conditions: Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT01746173

    CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

    Not yet reported Dana-Farber Cancer Institute 5 participants Est. completion 2014-10 2 sites Stand-alone
    Other conditions: T-cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Terminated NCT NCT01749293

    Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation

    Not yet reported University of Illinois at Chicago 3 participants Est. completion 2014-05-15 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT01796197

    Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

    Not yet reported Dana-Farber Cancer Institute 23 participants Est. completion 2026-01 3 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01807611

    Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy

    Not yet reported St. Jude Children's Research Hospital 82 participants Est. completion 2021-09-27 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT01839097

    Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)

    Not yet reported Acrotech Biopharma Inc. 23 participants Est. completion 2016-01 8 sites Stand-alone
    Other conditions: Peripheral T-cell Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT01854372

    Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement.

    Not yet reported The University of Texas Health Science Center at San Antonio Est. completion 2013-11 Stand-alone
    Other conditions: Newly Diagnosed Diffuse Large B-Cell Lymphoma, Intermediate (Burkitt-Like) Lymphoma
    View official trial listing →
  • Completed NCT NCT01857232

    Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy

    Not yet reported Acacia Pharma Ltd 342 participants Est. completion 2015-02 1 site
    Other conditions: CINV
    View official trial listing →
  • Completed NCT NCT01857934

    Therapy for Children With Advanced Stage Neuroblastoma

    Not yet reported St. Jude Children's Research Hospital 153 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT01862926

    Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD

    Not yet reported, Not yet reported Royal Brompton & Harefield NHS Foundation Trust 104 participants Est. completion 2021-01 1 site
    Other conditions: Interstitial Lung Disease, Scleroderma, Idiopathic Inflammatory Myositis, Mixed Connective Tissue Disease
    View official trial listing →
  • Completed NCT NCT01875601

    NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

    Not yet reported National Cancer Institute (NCI) 16 participants Est. completion 2015-09-08 1 site Stand-alone
    Other conditions: Solid Tumors, Brain Tumors, Sarcoma, Pediatric Cancers, Neuroblastoma
    View official trial listing →
  • Status unknown NCT NCT01907529

    A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer

    Not yet reported, Not yet reported Hebei Medical University Fourth Hospital 300 participants Est. completion 2021-12 1 site Stand-alone
    Other conditions: Stage III Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01910844

    Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes

    Not yet reported Centre Jean Perrin 3 participants Est. completion 2016-09 1 site Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT01928589

    Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer

    Not yet reported Richard Zellars 81 participants Est. completion 2028-12 10 sites
    Other conditions: Breast Cancer, Adenocarcinoma of the Breast
    View official trial listing →
  • Active, not recruiting NCT NCT01959698

    Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma

    Not yet reported Roswell Park Cancer Institute 29 participants Est. completion 2026-12-01 1 site
    Other conditions: CD20 Positive, Recurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Stage I Diffuse Large B-Cell Lymphoma, Stage II Diffuse Large B-Cell Lymphoma, Stage III Diffuse Large B-Cell Lymphoma, Stage IV Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01966289

    SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18 participants Est. completion 2020-06-06 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01976182

    Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia

    Not yet reported Rennes University Hospital 166 participants Est. completion 2024-10-07 59 sites
    Other conditions: Large Granular Lymphocytes Leukemia
    View official trial listing →
  • Status unknown NCT NCT01995331

    Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia

    Not yet reported Xiaofan Zhu 30 participants Est. completion 2015-03 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02005783

    Study of Danggui Buxue Decoction in Preventing Neutropenia

    Not yet reported Shanghai Jiao Tong University School of Medicine 50 participants Est. completion 2015-10 1 site Stand-alone
    Other conditions: Grade 3/4 Neutropenia, Febrile Neutropenia
    View official trial listing →
  • Terminated NCT NCT02013375

    SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD

    Not yet reported Damiano Rondelli, MD 2 participants Est. completion 2018-09-07 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT02018861

    A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101)

    Not yet reported, Not yet reported Incyte Corporation 88 participants Est. completion 2021-04-12 7 sites
    Other conditions: B-Cell Malignancies
    View official trial listing →
  • Terminated NCT NCT02043587

    Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma

    Not yet reported University of California, San Diego 31 participants Est. completion 2022-04-14 4 sites Stand-alone
    Other conditions: Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT02106988

    Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma

    Not yet reported M.D. Anderson Cancer Center 26 participants Est. completion 2034-01-31 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT02132949

    A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

    Not yet reported Hoffmann-La Roche 401 participants Est. completion 2020-08-25 80 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02167958

    Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source

    Not yet reported Rafic Farah, MD 28 participants Est. completion 2019-09-21 1 site Stand-alone
    Other conditions: Leukemia, MDS, Myelofibrosis, Lymphoma
    View official trial listing →
  • Terminated NCT NCT02187367

    Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients

    Not yet reported Bioven Europe 106 participants Est. completion 2019-09-06 51 sites Stand-alone
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Completed NCT NCT02191930

    Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma

    Not yet reported University of Cologne 70 participants Est. completion 2022-03-16 1 site Stand-alone
    Other conditions: Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT02193880

    Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT)

    Not yet reported Ayman Saad 7 participants Est. completion 2018-03-13 1 site
    Other conditions: Hematologic Neoplasms, Graft-Versus-Host Disease
    View official trial listing →
  • Completed NCT NCT02215967

    Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma

    Not yet reported National Cancer Institute (NCI) 30 participants Est. completion 2019-08-15 1 site Stand-alone
    Other conditions: Myeloma, Plasma-Cell, Myeloma-Multiple
    View official trial listing →
  • Completed NCT NCT02217163

    Carfilzomib, Cyclophosphamide, Dexamethasone in Transplant Eligible Newly Diagnosed High-risk Multiple Myeloma

    Not yet reported Singapore General Hospital 30 participants Est. completion 2020-10 2 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02219737

    Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 26 participants Est. completion 2017-05-11 1 site
    Other conditions: CD20 Positive, Recurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02223208

    Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas

    Not yet reported, Not yet reported Fondazione Italiana Linfomi - ETS 89 participants Est. completion 2026-03-25 27 sites Stand-alone
    Other conditions: Peripheral T-cell Lymphomas (PTCL), PTCL-NOS, Angioimmunoblastic T-cell Lymphoma (AITL), ALK- Anaplastic Large Cell Lymphoma (ALCL), Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin
    View official trial listing →
  • Withdrawn NCT NCT02225795

    Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.

    Not yet reported TriStar Health Est. completion 2019-12 Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02256150

    A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis

    Not yet reported Asahi Kasei Therapeutics Corporation 250 participants Est. completion 2019-03 26 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Terminated NCT NCT02323230

    A Study of DPX-Survivac Vaccine Therapy in Patients With Recurrent Survivin-expressing DLBCL

    Not yet reported ImmunoVaccine Technologies, Inc. (IMV Inc.) 4 participants Est. completion 2018-02 2 sites Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02339441

    Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis

    University of Manchester 320 participants Est. completion 2016-03
    Other conditions: Early Diffuse Cutaneous Systemic Sclerosis
    View official trial listing →
  • Completed NCT NCT02339532

    Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status

    Not yet reported UNICANCER 86 participants Est. completion 2024-07-08 12 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02349178

    Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT

    Not yet reported Medical College of Wisconsin 6 participants Est. completion 2017-03-16 4 sites Stand-alone
    Other conditions: Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02356159

    Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    Not yet reported, Not yet reported National Cancer Institute (NCI) 34 participants Est. completion 2025-03-25 2 sites Stand-alone
    Other conditions: Myelodysplastic Syndromes, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Leukemia, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02365805

    Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast Cancer

    Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 30 participants Est. completion 2016-10-10 7 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02375984

    A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas

    Not yet reported Saint John's Cancer Institute 1 participants Est. completion 2017-06-01 1 site Stand-alone
    Other conditions: Metastatic Melanoma
    View official trial listing →
  • Completed NCT NCT02388594

    A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients

    Not yet reported University of Pennsylvania 14 participants Est. completion 2019-03 1 site Stand-alone
    Other conditions: Human Immunodeficiency Virus (HIV)
    View official trial listing →
  • Active, not recruiting NCT NCT02405676

    BNHL-2015 for Children or Adolescents in China

    Not yet reported, Not yet reported Children's Cancer Group, China 200 participants Est. completion 2029-12 1 site
    Other conditions: Mature B-cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT02406222

    Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)

    Not yet reported University of Leeds 124 participants Est. completion 2025-06 21 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02413320

    Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer

    Not yet reported Priyanka Sharma 101 participants Est. completion 2020-02-01 9 sites
    Other conditions: Triple-negative Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02414269

    Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 113 participants Est. completion 2027-04-30 6 sites Stand-alone
    Other conditions: Malignant Pleural Disease, Mesothelioma, Metastases, Lung Cancer, Breast Cancer
    View official trial listing →
  • Completed NCT NCT02441803

    Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)

    Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2021-09-22 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Status unknown NCT NCT02499367

    Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients

    Not yet reported The Netherlands Cancer Institute 84 participants Est. completion 2025-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02506777

    Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.

    Not yet reported N.N. Petrov National Medical Research Center of Oncology 96 participants Est. completion 2020-08 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02527746

    Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

    Not yet reported EVIVE Biotechnology 18 participants Est. completion 2013-12 Stand-alone
    Other conditions: Neutropenia, Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02562365

    Adjuvant Chemotherapy of Three-step Regimen in Ovarian Cancer

    Not yet reported Xiaohua Wu MD 130 participants Est. completion 2023-11 1 site Stand-alone
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02567435

    Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

    Not yet reported National Cancer Institute (NCI) 325 participants Est. completion 2026-10-27 382 sites Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Active, not recruiting NCT NCT02568839

    Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer

    Not yet reported, Not yet reported Thomas Hatschek 202 participants Est. completion 2029-02 7 sites Stand-alone
    Other conditions: Early-Stage Breast Carcinoma, HER-2 Positive Breast Cancer
    View official trial listing →
  • Suspended NCT NCT02579005

    Radio-Immuno-Modulation in Lung Cancer

    Not yet reported Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 24 participants Est. completion 2025-04 1 site Stand-alone
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT02586038

    STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS

    Not yet reported Mario Boccadoro 175 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02617485

    MabionCD20 Compared to MabThera in Lymphoma Patients

    Not yet reported Mabion SA 143 participants Est. completion 2018-01 35 sites Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT02636322

    Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib

    Not yet reported M.D. Anderson Cancer Center 60 participants Est. completion 2022-10-24 1 site Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma Unclassifiable
    View official trial listing →
  • Status unknown NCT NCT02639650

    Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

    Not yet reported Weiguo Lv 214 participants Est. completion 2026-03-01 1 site
    Other conditions: Gestational Trophoblastic Neoplasms
    View official trial listing →
  • Completed NCT NCT02652455

    Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 11 participants Est. completion 2020-08-30 1 site Stand-alone
    Other conditions: Melanoma (Skin), Skin Cancer
    View official trial listing →
  • Status unknown NCT NCT02660762

    Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL

    Not yet reported Sun Yat-sen University 100 participants Est. completion 2019-01 1 site Stand-alone
    Other conditions: Leukaemia,Lymphoblastic
    View official trial listing →
  • Status unknown NCT NCT02685670

    Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma

    Not yet reported, Not yet reported The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine 20 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Refractory Chronic Lymphocytic Leukemia, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT02706405

    JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

    Not yet reported Fred Hutchinson Cancer Center 30 participants Est. completion 2021-05-28 1 site Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements, Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT02709993

    Consolidation Therapy in Patients With Hematologic Malignancies

    Not yet reported, Not yet reported Kiromic BioPharma Inc. Est. completion 2020-10-31 1 site Stand-alone
    Other conditions: Cancer, Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT02723994

    A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

    Not yet reported Incyte Corporation 171 participants Est. completion 2026-03-03 111 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT02757885

    Transplantation for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow

    Not yet reported Emory University 10 participants Est. completion 2021-12-14 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Status unknown NCT NCT02846584

    a Clinical Research of Sequential CAR-T Bridging HSCT in the Treatment of Relapse/Refractory B-cell Malignancies

    Not yet reported Southwest Hospital, China 100 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: Lymphoma, Large B-Cell, Diffuse, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma，Malignant
    View official trial listing →
  • Withdrawn NCT NCT02863913

    PD-1 Knockout Engineered T Cells for Muscle-invasive Bladder Cancer

    Not yet reported Peking University Est. completion 2019-09 1 site Stand-alone
    Other conditions: Invasive Bladder Cancer Stage IV
    View official trial listing →
  • Status unknown NCT NCT02871869

    Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma

    Not yet reported, Not yet reported Xinjiang Medical University 316 participants Est. completion 2021-12 1 site Stand-alone
    Other conditions: Diffuse, Large B-Cell, Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT02875314

    HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

    Not yet reported Parth Patel 250 participants Est. completion 2030-12 62 sites Stand-alone
    Other conditions: Medulloblastoma, Central Nervous System Embryonal Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT02876107

    Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

    Not yet reported M.D. Anderson Cancer Center 42 participants Est. completion 2027-10-31 1 site Stand-alone
    Other conditions: Breast Carcinoma, Breast Lump, Edema, Erythema, Estrogen Receptor Negative, HER2/Neu Negative, Inflammatory Breast Carcinoma, Invasive Breast Carcinoma, Peau d'Orange, Progesterone Receptor Negative, Triple-Negative Breast Carcinoma
    View official trial listing →
  • Status unknown NCT NCT02879513

    Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

    Not yet reported RenJi Hospital 290 participants Est. completion 2022-12 1 site
    Other conditions: Invasive Ductal Breast Cancer, Tubular Breast Cancer, Mucinous Breast Cancer, Inflammatory Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02879526

    Chidamide Combined With Cyclophosphamide, Prednisone, Thalidomide in Treatment of Fragile Patients With Relapse/Refratory Peripheral T Cell Lymphoma

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 45 participants Est. completion 2019-08 2 sites Stand-alone
    Other conditions: Relapse/Refratory Peripheral T Cell Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT02889523

    Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy

    Not yet reported, Not yet reported The Lymphoma Academic Research Organisation 214 participants Est. completion 2029-09 31 sites Stand-alone
    Other conditions: Lymphoma, DLBCL, Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT02890602

    Erythropoietin for Management of Anemia Caused by Chemotherapy

    Not yet reported Kosin University Gospel Hospital 53 participants Est. completion 2017-12-07
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02903524

    Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer

    Not yet reported Hebei Medical University Fourth Hospital 300 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02914470

    Carboplatin-cyclophosphamide Combined With Atezolizumab

    Not yet reported The Netherlands Cancer Institute 12 participants Est. completion 2021-10 1 site Stand-alone
    Other conditions: Breast Cancer, Cervix Cancer, Ovarian Cancer, Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT02978495

    Neoadjuvant Carboplatin in Triple Negative Breast Cancer

    Not yet reported Barretos Cancer Hospital 154 participants Est. completion 2021-10-22 1 site Stand-alone
    Other conditions: BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
    View official trial listing →
  • Completed NCT NCT03003676

    A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade

    Not yet reported Targovax Oy 21 participants Est. completion 2020-10 4 sites Stand-alone
    Other conditions: Advanced or Unresectable Melanoma Progressing After PD1 Blockade
    View official trial listing →
  • Status unknown NCT NCT03022123

    The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma

    Not yet reported Hebei Medical University Fourth Hospital 270 participants Est. completion 2018-03 1 site Stand-alone
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT03032783

    A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 51 participants Est. completion 2025-12-02 1 site Stand-alone
    Other conditions: Hematopoietic and Lymphoid Cell Neoplasm
    View official trial listing →
  • Status unknown NCT NCT03043105

    TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial

    Not yet reported Peking Union Medical College Hospital 25 participants Est. completion 2021-01-01 1 site Stand-alone
    Other conditions: Multicentric Castleman Disease
    View official trial listing →
  • Active, not recruiting NCT NCT03113500

    Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma

    Not yet reported City of Hope Medical Center 48 participants Est. completion 2027-04-25 5 sites Stand-alone
    Other conditions: Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive, Angioimmunoblastic T-Cell Lymphoma, Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma, Ann Arbor Stage III Noncutaneous Anaplastic Large Cell Lymphoma, Ann Arbor Stage IV Noncutaneous Anaplastic Large Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Hepatosplenic T-Cell Lymphoma, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified
    View official trial listing →
  • Terminated NCT NCT03136406

    QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. 3 participants Est. completion 2019-11-01 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT03146234

    CAR-GPC3 T Cells in Patients With Refractory Hepatocellular Carcinoma

    Not yet reported RenJi Hospital 7 participants Est. completion 2018-10-18 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT03151044

    R±CEOP90 Versus R±CEOP75 in Newly Diagnosed Young Patients With Medium/High-risk DLBCL

    Not yet reported FENG Ji-feng 408 participants Est. completion 2017-07 9 sites Stand-alone
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT03173417

    Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T)

    Not yet reported, Not yet reported Beijing Immunochina Medical Science & Technology Co., Ltd. 177 participants Est. completion 2019-05-01 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Status unknown NCT NCT03188172

    MUK Nine b: OPTIMUM Treatment Protocol

    Not yet reported University of Leeds 95 participants Est. completion 2026-05-31 21 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT03198195

    Post-transplant Cyclophosphamide in Wiskott-Aldrich Syndrome

    Capital Research Institute of Pediatrics 5 participants Est. completion 2020-07-10
    Other conditions: Wiskott-Aldrich Syndrome
    View official trial listing →
  • Terminated NCT NCT03202446

    Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer

    Not yet reported Eske Corporation S.A.C 18 participants Est. completion 2018-01 4 sites Stand-alone
    Other conditions: Breast Cancer Stage IIIA, Breast Cancer, Stage IIIB, Breast Cancer Stage IV
    View official trial listing →
  • Completed NCT NCT03215524

    A Study Of Daratumumab, Low-Dose Oral Dexamethasone and Cyclophosphamide With Or Without Pomalidomide

    Not yet reported Canadian Myeloma Research Group 120 participants Est. completion 2022-06-24 11 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Active, not recruiting NCT NCT03233854

    CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

    Not yet reported Stanford University 56 participants Est. completion 2035-09-01 1 site Stand-alone
    Other conditions: B Acute Lymphoblastic Leukemia, CD19 Positive, Minimal Residual Disease, Philadelphia Chromosome Positive
    View official trial listing →
  • Status unknown NCT NCT03250546

    Haploidentical and Mismatched Unrelated Donors Hematopoietic Stem Cell Transplant

    Not yet reported Assistance Publique - Hôpitaux de Paris 184 participants Est. completion 2022-11-30 2 sites
    Other conditions: Hematopoietic Stem Cell Transplant
    View official trial listing →
  • Status unknown NCT NCT03252600

    Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis

    Not yet reported Barbara Ann Karmanos Cancer Institute 53 participants Est. completion 2023-12-07 5 sites Stand-alone
    Other conditions: Recurrent Primary Amyloidosis
    View official trial listing →
  • Status unknown NCT NCT03256071

    Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT

    Not yet reported, Not yet reported The First Affiliated Hospital of Soochow University 90 participants Est. completion 2021-09 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning
    View official trial listing →
  • Completed NCT NCT03263559

    Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)

    Not yet reported Medical College of Wisconsin 95 participants Est. completion 2025-01-29 32 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT03289455

    CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL)

    Not yet reported, Not yet reported Autolus Limited 23 participants Est. completion 2020-05-18 3 sites Stand-alone
    Other conditions: B Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Refractory Childhood Acute Lymphoblastic Leukemia, B-cell Acute Lymphoblastic Leukemia
    View official trial listing →
  • Status unknown NCT NCT03294577

    Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia

    Not yet reported BeyondSpring Pharmaceuticals Inc. 221 participants Est. completion 2025-09-25 20 sites Stand-alone
    Other conditions: Chemotherapy-induced Neutropenia
    View official trial listing →
  • Completed NCT NCT03296137

    Adoptive Cell Therapy Across Cancer Diagnoses

    Not yet reported, Not yet reported Inge Marie Svane 25 participants Est. completion 2020-07-01 1 site Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT03304756

    Study of Neoadjuvant Treatment of Locally Advanced Breast Cancer With CAP Regimen

    Not yet reported Instituto Nacional de Cancer, Brazil 41 participants Est. completion 2014-12-15 Stand-alone
    Other conditions: Triple Negative Breast Cancer Patients
    View official trial listing →
  • Terminated NCT NCT03320642

    GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

    Not yet reported Incyte Corporation 84 participants Est. completion 2022-02-17 17 sites Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Status unknown NCT NCT03357159

    Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic Transplantation

    Not yet reported Sheba Medical Center 30 participants Est. completion 2024-12-01 1 site Stand-alone
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT03441100

    TCR-engineered T Cells in Solid Tumors: IMA202-101

    Not yet reported Immatics US, Inc. 16 participants Est. completion 2023-03-17 6 sites Stand-alone
    Other conditions: Solid Tumor, Adult, Refractory Cancer, Recurrent Cancer, Cancer
    View official trial listing →
  • Suspended NCT NCT03467386

    Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia

    Not yet reported City of Hope Medical Center 56 participants Est. completion 2026-09-06 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT03475758

    Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide

    Not yet reported Assiut University 100 participants Est. completion 2020-03
    Other conditions: Ovarian Failure
    View official trial listing →
  • Terminated NCT NCT03492255

    CYCLONES - CYClophosphamide LOw Dose and No Extra Steroid

    Not yet reported University of Sao Paulo General Hospital 49 participants Est. completion 2021-07-02 2 sites Stand-alone
    Other conditions: Systemic Lupus Erythematosus (SLE)
    View official trial listing →
  • Completed NCT NCT03514381

    Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma

    Not yet reported Institut Claudius Regaud 59 participants Est. completion 2020-11-23 3 sites
    Other conditions: Soft Tissue Sarcoma
    View official trial listing →
  • Status unknown NCT NCT03550781

    Anti-inflammatory Treatment for Inactive Takayasu Arteritis

    Not yet reported, Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 40 participants Est. completion 2021-05-31 Stand-alone
    Other conditions: Takayasu Arteritis, Anti-Inflammatory Agents
    View official trial listing →
  • Terminated NCT NCT03610490

    Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma

    Not yet reported M.D. Anderson Cancer Center 16 participants Est. completion 2024-08-21 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Malignant Solid Neoplasm, Metastatic Colorectal Adenocarcinoma, Metastatic Ovarian Carcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Platinum-Resistant Ovarian Carcinoma, Recurrent High Grade Ovarian Serous Adenocarcinoma, Refractory Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8
    View official trial listing →
  • Status unknown NCT NCT03629873

    Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 69 participants Est. completion 2021-12-31 1 site
    Other conditions: Lymphoma, Large B-Cell, Diffuse, Mantle Cell Lymphoma, Peripheral T Cell Lymphoma, Double-hit Lymphoma
    View official trial listing →
  • Completed NCT NCT03666871

    CCR5-modified CD4+ T Cells for HIV Infection

    Not yet reported, Not yet reported University of Cincinnati 30 participants Est. completion 2024-02-28 1 site Stand-alone
    Other conditions: HIV Infections
    View official trial listing →
  • Status unknown NCT NCT03689465

    PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

    Not yet reported Nanfang Hospital, Southern Medical University 260 participants Est. completion 2020-12-31 7 sites
    Other conditions: Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT03700450

    Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma

    Not yet reported Universitätsklinikum Hamburg-Eppendorf 37 participants Est. completion 2022-12-01 3 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Active, not recruiting NCT NCT03749018

    Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma

    Not yet reported David Bond, MD 30 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Diffuse Large B-Cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma, Not Otherwise Specified, Indolent Non-Hodgkin Lymphoma, Mediastinal B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma, Transformed Non-Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT03759093

    CURATE.AI Optimized Modulation for Multiple Myeloma

    Not yet reported, Not yet reported National University Hospital, Singapore 20 participants Est. completion 2025-09-10 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT03791827

    Multicenter Registry of Pediatric Lupus Nephritis in China

    Xiqiang Dang 1200 participants Est. completion 2024-11-30 1 site
    Other conditions: Lupus Nephritis, Children, Steroid, Immunosuppressive Treatment
    View official trial listing →
  • Completed NCT NCT03800836

    A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer

    Not yet reported Hoffmann-La Roche 139 participants Est. completion 2022-03-16 18 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03801083

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

    Not yet reported Udai Kammula 4 participants Est. completion 2031-01-31 1 site Stand-alone
    Other conditions: Biliary Tract Cancer, Cholangiocarcinoma, Biliary Tract Neoplasms
    View official trial listing →
  • Status unknown NCT NCT03837873

    DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 118 participants Est. completion 2024-09-01 6 sites Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Transformed Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT03842696

    Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

    Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 43 participants Est. completion 2026-04-01 7 sites Stand-alone
    Other conditions: Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase, Chronic Myelogenous Leukemia, Accelerated Phase, Chronic Myelogenous Leukemia, Blastic Phase, Myelodysplastic Syndromes, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Non Hodgkin Lymphoma, Graft Vs Host Disease, Graft-versus-host-disease
    View official trial listing →
  • Active, not recruiting NCT NCT03875573

    Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:

    Not yet reported Jules Bordet Institute 147 participants Est. completion 2029-09-30 7 sites Stand-alone
    Other conditions: Luminal B
    View official trial listing →
  • Completed NCT NCT03879512

    Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG

    Not yet reported, Not yet reported Wuerzburg University Hospital 24 participants Est. completion 2024-07-31 1 site Stand-alone
    Other conditions: Childhood Glioblastoma
    View official trial listing →
  • Status unknown NCT NCT03910842

    Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

    Not yet reported Timmune Biotech Inc. 12 participants Est. completion 2022-10-15 1 site Stand-alone
    Other conditions: Non-Hodgkin Lymphoma of Intestine, Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT03936829

    Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes

    Not yet reported Children's Hospital of Fudan University 10 participants Est. completion 2030-05-31 1 site Stand-alone
    Other conditions: Lipodystrophy Acquired, Type1diabetes
    View official trial listing →
  • Completed NCT NCT03983538

    Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer

    New Mexico Cancer Research Alliance 10 participants Est. completion 2018-01-28 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04002401

    Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Rituximab in Participants With Refractory Large B-Cell Lymphoma

    Not yet reported Kite, A Gilead Company 27 participants Est. completion 2023-01-30 14 sites Stand-alone
    Other conditions: Refractory Large B-cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT04004637

    CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia

    Not yet reported PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10 participants Est. completion 2021-06-01 1 site Stand-alone
    Other conditions: T-lymphoblastic Lymphoma, NK/T Cell Lymphoma, Acute Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT04010968

    Evaluation of Risk-Adapted and MRD-Driven Strategy for Untreated Fit Patients With Intermediate Risk Chronic Lymphocytic Leukemia

    Not yet reported French Innovative Leukemia Organisation 120 participants Est. completion 2025-01-30 34 sites
    Other conditions: Intermediate Risk Chronic Lymphocytic Leukemia, Fit Patients, Risk-Adapted and MRD-Driven Strategy
    View official trial listing →
  • Completed NCT NCT04024462

    A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer

    Not yet reported Hoffmann-La Roche 200 participants Est. completion 2026-01-19 18 sites Stand-alone
    Other conditions: HER2-positive Early Breast Cancer
    View official trial listing →
  • Completed NCT NCT04030195

    Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL

    Not yet reported, Not yet reported Precision BioSciences, Inc. 18 participants Est. completion 2021-06-24 5 sites Stand-alone
    Other conditions: Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory, Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-cell Chronic Lymphocytic Leukemia, B-cell Non Hodgkin Lymphoma, Small Lymphocytic Lymphoma
    View official trial listing →
  • Status unknown NCT NCT04044222

    A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy

    Not yet reported Innovent Biologics (Suzhou) Co. Ltd. 240 participants Est. completion 2024-12-31 1 site
    Other conditions: Classic Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT04088890

    Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies

    Not yet reported Matthew Frank 52 participants Est. completion 2025-03-07 1 site Stand-alone
    Other conditions: B-ALL, B-cell Non Hodgkin Lymphoma, DLBCL, Follicular Lymphoma Grade 3B
    View official trial listing →
  • Status unknown NCT NCT04138979

    Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy

    First Affiliated Hospital of Harbin Medical University 80 participants Est. completion 2020-10-15 1 site
    Other conditions: Microbiota
    View official trial listing →
  • Active, not recruiting NCT NCT04166565

    Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease

    Not yet reported Stichting European Myeloma Network 41 participants Est. completion 2027-03 8 sites Stand-alone
    Other conditions: Multiple Myeloma, Extramedullary Plasmacytoma
    View official trial listing →
  • Status unknown NCT NCT04191941

    Treatment of Hematological Malignancy With Novel CAR-T Cells.

    Not yet reported Timmune Biotech Inc. 9 participants Est. completion 2021-12-31 1 site Stand-alone
    Other conditions: B-cell Non Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia, Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT04203017

    Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis

    Not yet reported St. Petersburg State Pavlov Medical University 20 participants Est. completion 2023-11-29 1 site Stand-alone
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT04224922

    Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer

    Not yet reported Universitair Ziekenhuis Brussel 63 participants Est. completion 2017-05 18 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04231877

    Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma

    Not yet reported University of Washington 56 participants Est. completion 2031-12-01 1 site Stand-alone
    Other conditions: Aggressive Non-Hodgkin Lymphoma, ALK-Positive Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma, Not Otherwise Specified, Primary Mediastinal Large B-Cell Lymphoma, T-Cell/Histiocyte-Rich Large B-Cell Lymphoma, Gray-Zone Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT04293393

    Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients

    Not yet reported Spanish Breast Cancer Research Group 200 participants Est. completion 2033-02-28 28 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04304352

    Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer Patients

    Not yet reported European Institute of Oncology 162 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04317248

    "Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma

    Not yet reported Yuehua Huang 600 participants Est. completion 2022-04-30 4 sites Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT04369495

    BAFF Levels and Lupus Nephritis (LN)

    Universidad de Antioquia Est. completion 2023-01
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Active, not recruiting NCT NCT04388839

    Evolutionary Therapy for Rhabdomyosarcoma

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 12 participants Est. completion 2027-08 18 sites Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Active, not recruiting NCT NCT04404660

    A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

    Not yet reported, Not yet reported Autolus Limited 153 participants Est. completion 2029-06-30 34 sites Stand-alone
    Other conditions: Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT04511871

    A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors

    Not yet reported Shanghai PerHum Therapeutics Co., Ltd. 12 participants Est. completion 2025-03-29 1 site Stand-alone
    Other conditions: Solid Tumor, Gastric Cancer, Breast Cancer, Ovarian Cancer, Sarcoma
    View official trial listing →
  • Status unknown NCT NCT04516551

    Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT

    Not yet reported Xinqiao Hospital of Chongqing 18 participants Est. completion 2022-12-01 1 site Stand-alone
    Other conditions: Relapsed Adult ALL, B Cell Leukemia
    View official trial listing →
  • Status unknown NCT NCT04654195

    Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient

    Damanhour University 100 participants Est. completion 2021-02-01 1 site
    Other conditions: Breast Cancer Patients
    View official trial listing →
  • Active, not recruiting NCT NCT04697940

    Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL

    Not yet reported, Not yet reported Han weidong 33 participants Est. completion 2026-09-01 1 site Stand-alone
    Other conditions: Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma, Decitabine-primed Tandem CD19/CD20 CAR T Cells
    View official trial listing →
  • Status unknown NCT NCT04753177

    The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

    Not yet reported, Not yet reported Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary 120 participants Est. completion 2024-01-28 1 site Stand-alone
    Other conditions: The Neoadjuvant Therapy
    View official trial listing →
  • Status unknown NCT NCT04792593

    Senl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

    Not yet reported Hebei Senlang Biotechnology Inc., Ltd. 15 participants Est. completion 2022-02-10 1 site Stand-alone
    Other conditions: B-ALL
    View official trial listing →
  • Status unknown NCT NCT04796675

    Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27 participants Est. completion 2024-03-10 1 site Stand-alone
    Other conditions: Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin's Lymphoma
    View official trial listing →
  • Terminated NCT NCT04809766

    Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

    Not yet reported Fred Hutchinson Cancer Center 9 participants Est. completion 2025-01-15 1 site Stand-alone
    Other conditions: Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8
    View official trial listing →
  • Status unknown NCT NCT04880746

    Efficacy and Safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma: a Multicenter Clinical Study

    Not yet reported Ruijin Hospital 266 participants Est. completion 2025-10-17 1 site Stand-alone
    Other conditions: Peripheral T-cell Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT04904588

    HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

    Not yet reported Center for International Blood and Marrow Transplant Research 300 participants Est. completion 2026-12 39 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia, Acute Leukemia, Myelodysplastic Syndromes, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Lymphoma
    View official trial listing →
  • Terminated NCT NCT04973137

    A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis

    Not yet reported Prothena Biosciences Ltd. 208 participants Est. completion 2025-06-20 110 sites Stand-alone
    Other conditions: Light Chain (AL) Amyloidosis
    View official trial listing →
  • Terminated NCT NCT05001451

    Study of GDX012 in Patients With MRD Positive AML

    Not yet reported GammaDelta Therapeutics Limited 3 participants Est. completion 2022-06-03 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT05005299

    Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation

    Not yet reported Melbourne Health 18 participants Est. completion 2026-03-31 1 site Stand-alone
    Other conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Plasma Cell Myeloma
    View official trial listing →
  • Completed NCT NCT05051891

    A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-naїve Mantle Cell Lymphoma

    Not yet reported Beijing InnoCare Pharma Tech Co., Ltd. 3 participants Est. completion 2025-06-30 22 sites Stand-alone
    Other conditions: Treatment-naїve Mantle Cell Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT05075993

    Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

    Not yet reported M.D. Anderson Cancer Center 352 participants Est. completion 2027-02-02 1 site Stand-alone
    Other conditions: Metastatic Esophageal, Gastric Cancer, Metastatic Head and Neck Carcinoma, Metastatic Hepatocellular Carcinoma, Metastatic HPV Related Solid Tumors, Metastatic Ovarian Carcinoma, Metastatic Soft Tissue Sarcoma, Metastatic Uveal Melanoma
    View official trial listing →
  • Status unknown NCT NCT05155215

    Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma

    Not yet reported, Not yet reported Beijing Immunochina Medical Science & Technology Co., Ltd. 68 participants Est. completion 2023-02-28 Stand-alone
    Other conditions: Lymphoma, Lymphoma, Mantle-Cell, Neoplasms by Histologic Type, Neoplasms, Lymphoproliferative Disorders
    View official trial listing →
  • Active, not recruiting NCT NCT05176470

    Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

    Not yet reported Richard Wu 2 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Locally Advanced Melanoma, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Stage IV Melanoma
    View official trial listing →
  • Active, not recruiting NCT NCT05192889

    Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax

    Not yet reported, Not yet reported St. Jude Children's Research Hospital 35 participants Est. completion 2027-02 2 sites Stand-alone
    Other conditions: Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT05195086

    A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt

    Nada Magdy Mansour 122 participants Est. completion 2021-06-05 1 site
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Status unknown NCT NCT05206071

    Clinical Study of SL19+22 CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

    Not yet reported Hebei Senlang Biotechnology Inc., Ltd. 100 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Non-hodgkin's Lymphoma
    View official trial listing →
  • Status unknown NCT NCT05211557

    Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer

    Not yet reported, Not yet reported The Affiliated Hospital of Xuzhou Medical University 15 participants Est. completion 2026-08-31 1 site Stand-alone
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Withdrawn NCT NCT05218408

    CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type

    Not yet reported, Not yet reported Celularity Incorporated Est. completion 2021-10-23
    Other conditions: Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma, Glioblastoma Multiforme
    View official trial listing →
  • Active, not recruiting NCT NCT05257083

    A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma

    Not yet reported Stichting European Myeloma Network 759 participants Est. completion 2040-08 106 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT05290090

    ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL

    Not yet reported Zhejiang Cancer Hospital 31 participants Est. completion 2025-12-01 1 site Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT05292898

    A Triple-targeted Cell Preparation Targeting CD19/CD20/CD22 in Patients With Relapsed/Refractory B-cell Acute Lymphocytic Leukemia

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 10 participants Est. completion 2025-03-31 2 sites Stand-alone
    Other conditions: Acute Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT05315882

    Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis >> GVHD PROPHYLAXIS ERA

    Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 300 participants Est. completion 2020-12-17 1 site
    Other conditions: CMV Infection
    View official trial listing →
  • Completed NCT NCT05380713

    ......SMARTEST Trial......

    Not yet reported University Health Network, Toronto 30 participants Est. completion 2025-12-20 1 site Stand-alone
    Other conditions: Mesothelioma, Malignant
    View official trial listing →
  • Active, not recruiting NCT NCT05455697

    Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma

    Not yet reported, Not yet reported University of Washington 33 participants Est. completion 2027-01-07 1 site Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT05474690

    A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

    Not yet reported Henan Cancer Hospital Est. completion 2024-08-30 1 site Stand-alone
    Other conditions: Breast Cancer, HER2-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT05538195

    Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

    Not yet reported, Not yet reported Chongqing Precision Biotech Co., Ltd 17 participants Est. completion 2024-02-07 1 site Stand-alone
    Other conditions: Gastric Cancer, Colon Cancer, Rectal Cancer, Esophageal Cancer, Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT05563545

    Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia

    Not yet reported Shanghai Simnova Biotechnology Co.,Ltd. 2 participants Est. completion 2022-11-25 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Status unknown NCT NCT05580887

    Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients

    Moscow Clinical Scientific Center 35 participants Est. completion 2025-08 1 site
    Other conditions: Breast Cancer, Pancreas Cancer
    View official trial listing →
  • Status unknown NCT NCT05590221

    Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma

    Not yet reported Peking University Cancer Hospital & Institute 20 participants Est. completion 2024-12-10 4 sites Stand-alone
    Other conditions: B-cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT05595109

    Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

    Not yet reported, Not yet reported Tanta University 56 participants Est. completion 2024-10-28 1 site
    Other conditions: Breast Cancer, Peripheral Neuropathy, Cardiac Toxicities, Hepatic Toxicity, Cognitive Impairment
    View official trial listing →
  • Active, not recruiting NCT NCT05621759

    Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD

    Not yet reported NYU Langone Health 27 participants Est. completion 2027-01-30 1 site Stand-alone
    Other conditions: Graft Vs Host Disease
    View official trial listing →
  • Completed NCT NCT05622032

    Blood Virome After Haploidentical Hematopoietic Stem Cell Transplantation, a Pilot Study

    Laurent Kaiser 52 participants Est. completion 2025-03-25 1 site
    Other conditions: Haploidentical Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Enrolling by invitation NCT NCT05678933

    AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 200 participants Est. completion 2029-12-01 1 site Stand-alone
    Other conditions: Peripheral T-cell Lymphoma Targeted Therapy
    View official trial listing →
  • Terminated NCT NCT05813327

    Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma

    Not yet reported Washington University School of Medicine 6 participants Est. completion 2026-07-22 1 site
    Other conditions: Soft Tissue Sarcoma, Sts, Sarcoma,Soft Tissue
    View official trial listing →
  • Active, not recruiting NCT NCT05878184

    Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)

    Not yet reported Sana Biotechnology 16 participants Est. completion 2038-11-04 10 sites Stand-alone
    Other conditions: Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT05886335

    Influence of Timing PTCy in AlloSCT

    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 180 participants Est. completion 2025-01-31 1 site
    Other conditions: Cyclophosphamide Toxicity, Allogenic Haematopoetic Transplantation
    View official trial listing →
  • Not yet recruiting NCT NCT05909826

    Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM

    Not yet reported Dong-A University Hospital 49 participants Est. completion 2027-06-30 Stand-alone
    Other conditions: Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
    View official trial listing →
  • Withdrawn NCT NCT05934097

    FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma

    Not yet reported Fate Therapeutics Est. completion 2039-05 Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma, Transformed Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
    View official trial listing →
  • Completed NCT NCT05950334

    FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)

    Not yet reported Fate Therapeutics 20 participants Est. completion 2025-06-30 7 sites Stand-alone
    Other conditions: Relapsed/Refractory B-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT05959889

    Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer

    Not yet reported Damanhour University 50 participants Est. completion 2024-12-01 1 site
    Other conditions: Breast Cancer, Doxorubicin Induced Cardiotoxicity
    View official trial listing →
  • Status unknown NCT NCT06027853

    Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia

    Not yet reported Zhejiang University 24 participants Est. completion 2026-08-31 1 site
    Other conditions: AML, Adult
    View official trial listing →
  • Active, not recruiting NCT NCT06040320

    Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)

    Not yet reported, Not yet reported Washington University School of Medicine 12 participants Est. completion 2032-05-31 1 site Stand-alone
    Other conditions: Post-transplant Lymphoproliferative Disorder
    View official trial listing →
  • Status unknown NCT NCT06045585

    JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma

    Not yet reported Guangdong Second Provincial General Hospital 20 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Relapsed or Refractory B-cell Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT06098313

    HCT With PTCy in Higher-risk MDS

    Not yet reported Asan Medical Center 113 participants Est. completion 2027-05-31 1 site Stand-alone
    Other conditions: Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
    View official trial listing →
  • Active, not recruiting NCT NCT06098326

    CyFluATG in Lower Risk MDS

    Not yet reported Asan Medical Center 30 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT06144385

    A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma

    Not yet reported Shanghai Ming Ju Biotechnology Co., Ltd. 20 participants Est. completion 2024-12 1 site Stand-alone
    Other conditions: Liver Carcinoma, Hepatic Cell Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT06145282

    Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function

    Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 6 participants Est. completion 2027-11-26 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT06150651

    Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.

    Not yet reported Chulalongkorn University 3 participants Est. completion 2026-03-01 1 site Stand-alone
    Other conditions: SLE (Systemic Lupus)
    View official trial listing →
  • Withdrawn NCT NCT06205290

    A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies

    Not yet reported Juno Therapeutics, Inc., a Bristol-Myers Squibb Company Est. completion 2031-10-13 48 sites Stand-alone
    Other conditions: Leukemia, Lymphocytic, Chronic, B-Cell
    View official trial listing →
  • Status unknown NCT NCT06245707

    the Effects of Different Treatment Schemes on Cognitive Function of Patients With Idiopathic Membranous Nephropathy

    Not yet reported Beijing Friendship Hospital 2 participants Est. completion 2025-09-30 1 site Stand-alone
    Other conditions: Mild Cognitive Impairment, Idiopathic Membranous Nephropathy
    View official trial listing →
  • Status unknown NCT NCT06277011

    Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research

    Not yet reported Anhui Provincial Hospital 18 participants Est. completion 2025-05-15 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Non-hodgkin Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT06298266

    To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma

    Not yet reported Guangdong Second Provincial General Hospital 15 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Relapsed or Refractory Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT06316076

    Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases

    Not yet reported RenJi Hospital 48 participants Est. completion 2026-06 1 site Stand-alone
    Other conditions: Systemic Lupus Erythematosus, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Idiopathic Inflammatory Myopathies, Systemic Sclerosis
    View official trial listing →
  • Status unknown NCT NCT06324266

    Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation

    Not yet reported, Not yet reported Jinling Hospital, China 80 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Newly Diagnosed Multiple Myeloma
    View official trial listing →
  • Not yet recruiting NCT NCT06358053

    CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers

    Not yet reported Corregene Biotechnology Co., Ltd 24 participants Est. completion 2028-04-30 Stand-alone
    Other conditions: Cervical Cancer, Anal Cancer, Head and Neck Cancers, Other Solid Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT06358430

    Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)

    Not yet reported M.D. Anderson Cancer Center 10 participants Est. completion 2029-01-18 1 site Stand-alone
    Other conditions: Colorectal Cancer, Minimal Residual Disease
    View official trial listing →
  • Not yet recruiting NCT NCT06505551

    Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

    Not yet reported, Not yet reported SCG Cell Therapy Pte. Ltd. 66 participants Est. completion 2028-12 Stand-alone
    Other conditions: HPV-Related Squamous Cell Carcinoma, HPV-Related Cervical Squamous Cell Carcinoma, HPV-Related Vulvar Squamous Cell Carcinoma, HPV-Related Penile Squamous Cell Carcinoma, HPV-Related Vaginal Squamous Cell Carcinoma, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Head and Neck Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06607016

    A Clinical Trial With KJ103 in Anti-GBM Disease

    Not yet reported Shanghai Bao Pharmaceuticals Co., Ltd. 12 participants Est. completion 2026-03 1 site Stand-alone
    Other conditions: Anti-Glomerular Basement Membrane Disease
    View official trial listing →
  • Withdrawn NCT NCT06626256

    STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

    Not yet reported City of Hope Medical Center Est. completion 2027-10-30 Stand-alone
    Other conditions: Locally Advanced Cervical Carcinoma, Locally Advanced Colorectal Carcinoma, Locally Advanced Malignant Solid Neoplasm, Locally Advanced Melanoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Locally Advanced Renal Cell Carcinoma, Metastatic Cervical Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Melanoma, Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Renal Cell Carcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Cervical Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage III Renal Cell Cancer AJCC v8, Stage IV Cervical Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8, Unresectable Cervical Carcinoma, Unresectable Colorectal Carcinoma, Unresectable Malignant Solid Neoplasm, Unresectable Melanoma, Unresectable Pancreatic Ductal Adenocarcinoma, Unresectable Renal Cell Carcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT06652152

    Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor Lymphoma

    Ruijin Hospital 400 participants Est. completion 2025-12-30
    Other conditions: Diffuse Large B Cell Lymphoma (DLBCL), Double Expressor Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT06656962

    The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)

    Not yet reported, Not yet reported Renmin Hospital of Wuhan University 15 participants Est. completion 2026-10-30 1 site Stand-alone
    Other conditions: Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN)
    View official trial listing →
  • Not yet recruiting NCT NCT06673459

    BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients

    Not yet reported The First Affiliated Hospital of Soochow University 430 participants Est. completion 2029-11-30 1 site Stand-alone
    Other conditions: T-Cell Lymphocytic Leukemia, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Total Body Irradiation, Chemotherapy
    View official trial listing →
  • Not yet recruiting NCT NCT06701344

    Go-CHOP in de Novo Intestinal T-cell Lymphoma Patients

    Not yet reported Ruijin Hospital 7 participants Est. completion 2027-12-04 Stand-alone
    Other conditions: Enteropathy Associated T Cell Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT06890585

    Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL

    Not yet reported Li Zhiming 128 participants Est. completion 2029-12-31 1 site Stand-alone
    Other conditions: BTK Inhibitors, Histone Deacetylase Inhibitor, Double Express Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT06912529

    Axicabtagene Ciloleucel CAR T-cells in Patients With Relapsed or Refractory Primary Mediastinal B-cell Lymphoma

    Not yet reported Universität Münster 1 participants Est. completion 2025-07-25 1 site Stand-alone
    Other conditions: B-cell Lymphoma Refractory, B-cell Lymphoma Recurrent
    View official trial listing →
  • Not yet recruiting NCT NCT06930105

    Impact of Low-intensity Chemotherapy Combined With Short-course Blinatumomab on Allo-HSCT in Adults With Ph- B-ALL

    Not yet reported Xianmin Song, MD 45 participants Est. completion 2028-05-01 Stand-alone
    Other conditions: Acute Lymphoid Leukemia (ALL)
    View official trial listing →
  • Not yet recruiting NCT NCT07254858

    Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer

    Not yet reported First Affiliated Hospital of Wenzhou Medical University 302 participants Est. completion 2029-12-30 1 site Stand-alone
    Other conditions: HR+/HER2- Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07291102

    Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

    Not yet reported Nationwide Children's Hospital 96 participants Est. completion 2038-10 2 sites Stand-alone
    Other conditions: Medulloblastoma
    View official trial listing →
  • Not yet recruiting NCT NCT07317778

    Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 249 participants Est. completion 2033-09-15 1 site Stand-alone
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3), HR Positive/HER2 Low Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07355855

    A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma

    Not yet reported Fudan University 106 participants Est. completion 2029-01 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Not yet recruiting NCT NCT07444710

    Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 16 participants Est. completion 2027-09-01 Stand-alone
    Other conditions: Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma, Ann Arbor Stage IV Mantle Cell Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT07500805

    UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma

    Not yet reported UTC Therapeutics Inc. 21 participants Est. completion 2029-05-01 1 site Stand-alone
    Other conditions: CD70-positive Advanced Renal Clear Cell Carcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07569965

    Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCL

    Not yet reported Miltenyi Biomedicine GmbH 52 participants Est. completion 2030-03 Stand-alone
    Other conditions: Mantle Cell Lymphoma (MCL)
    View official trial listing →
  • Not yet recruiting NCT NCT07603557

    Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)

    Not yet reported Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 52 participants Est. completion 2030-05-06 8 sites Stand-alone
    Other conditions: Chronic Immune Thrombocytopenia, Autoimmune Hemolytic Anemia
    View official trial listing →
  • Not yet recruiting NCT NCT07677813

    Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma

    Not yet reported Ou Bai, MD/PHD 66 participants Est. completion 2031-12-31 1 site Stand-alone
    Other conditions: DLBCL - Diffuse Large B Cell Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT07793422

    Study to Evaluate Change in Disease Activity and Adverse Events of Subcutaneous Etentamig Compared With Daratumumab Plus Cyclophosphamide Plus Bortezomib Plus Dexamethasone (Dara-CyBorD) in Adults With Amyloid Light Chain (AL) Amyloidosis

    Not yet reported AbbVie 370 participants Est. completion 2034-12
    Other conditions: Amyloid Light Chain (AL) Amyloidosis
    View official trial listing →
  • Not yet recruiting NCT NCT07819396

    Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome

    Not yet reported Fred Hutchinson Cancer Center 52 participants Est. completion 2031-06-01 1 site Stand-alone
    Other conditions: Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Leukemia, Burkitt Lymphoma, Chronic Myeloid Leukemia, BCR-ABL1 Positive, Lymphoblastic Lymphoma, Mast Cell Leukemia, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT07834450

    Efficacy and Safety of Cyclophosphamide in Amyotrophic Lateral Sclerosis

    Not yet reported Huashan Hospital 60 participants Est. completion 2029-09-30 Stand-alone
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.